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Abstract
Vaping during Pregnancy: Effects on Vascular and Behavioral Outcomes in
Offspring
Eiman A. Aboaziza
Electronic cigarette (e-cig) use is increasing due to aggressive marketing,
tempting flavors, and seemingly higher acceptability in the community (lesser perceived
social stigma) despite unproven claims of safety. In an alarming trend, pregnant women
smokers have turned to novel “modified risk” products, such as e-cigs, in response to
heavy marketing of e-cigs as safer alternatives to cigarettes and a tool to help quit
smoking. This is despite proven detrimental effects of nicotine on a growing fetus, and
scarcity of information regarding toxicity of e-liquid (with and without nicotine) on child
development. Moreover, rampant e-cig use among youth (nearly 4 million in 2018,
CDC) reflects a growing population of experienced and addicted female users who may
become pregnant. This project addresses this emerging public health issue by providing
information regarding consequences of maternal e-cig use and its long-term effects on
child health outcomes.
It is established that both mother and fetus are vulnerable to environmental
exposures during pregnancy. Prenatal exposure to nicotine leads to preterm births and
is linked to adverse health, behavioral and cognitive outcomes in newborns. E-cigs have
been shown to deliver physiologically significant amounts of nicotine to its users.
Currently, little is known about the effects of e-cig use on perinatal and developmental
outcomes and whether adverse effects can be attributed to nicotine delivery alone.
Given the paucity of data, this overall goal project seeks to elucidate the impact of
maternal e-cig use during pregnancy using an animal model to test cardiovascular and
behavioral outcomes.
The first objective of this work was to determine dose-dependent effects of
maternal e-cig exposure on functional vascular outcomes in conduit and resistance
vessel beds and to investigate potential pathways that lead to this impairment. The
second objective is to evaluate the effect of on cognitive development and behavioral
deficits in the pups and compare between levels of exposure. The hypothesis is that 1)
maternal e-cig exposure will lead to increased arterial stiffness and reduced vascular
reactivity in aorta and middle cerebral artery, and this impairment will be at least
partially mediated by the nitric oxide pathway; and 2) pups exposed to e-cig aerosol in
utero will demonstrate hyperactivity, exploratory behavior, and impaired spatial and
aversive learning as well as impaired memory.
The specific aims are to (1) determine dose-dependent effect of maternal e-cig
vapor exposure (with and without nicotine) on arterial stiffness and vascular reactivity in
offspring and (2) evaluate cognitive development and behavioral changes in pups
exposed to e-cig vapor in utero using a battery of tests to tap different functional
domains of learning and memory.
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Chapter 1: Review of Literature

I. Electronic cigarettes

Electronic cigarettes (e-cigs) are increasing in popularity and are currently a $2.5
billion industry in the United States. Globally, the e-cig market is over $14 billion in 2018
and is expected to more than double in 2022.[1] The World Health Organization (WHO)
has more accurately termed e-cigs as electronic nicotine delivery systems (ENDS), based
on their primary purpose and function. E-cigs are battery-powered handheld devices that
heat a solution (e-liquid) turning it into an aerosol cloud that is inhaled. The e-cig market
is highly heterogeneous, rapidly changing, and beset with many combinations of devices
and liquids. Based on the U.S. nationally representative 2020 National Health Interview
Survey, 3.7 % of adults (9.1 million) currently use e-cigs, with prevalence highest among
adults aged 18–24 (9.4 %).
There is substantial market diversity in e-cig design although, fundamentally, these
devices operate similarly. Every model includes certain key components including an eliquid storage tank or pod, power source, heating element, and a means of producing
aerosol at the e-liquid/heating element interface. Different device components (e.g.,
battery longevity, e-liquid capacity, coil replacement frequency, thermal and electrical
properties) all contribute independently and in clinically relevant ways to the generation
of the aerosol.[2] Additionally, a device’s power characteristics (wattage: a function of
battery voltage and heating coil resistance), nicotine concentration of the liquid, and
nicotine form (salt or free-base) all influence the amount of nicotine delivered to the
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user.[3] These parameters are further complicated by length and/or frequency of an e-cig
user’s sessions. Additionally, higher temperatures increase the production of toxic
carbonyl compounds, including but not limited to, formaldehyde, acetaldehyde, and
acrolein.[4]
Toxic metallic nanoparticles are generated across different heating element
brands and designs, and the longer a coil is in contact with e-liquid, the more heavy metals
are released. The small size of these nanoparticles allows them to easily penetrate the
airway defenses and be systemically absorbed.[2, 5] Mulder et al. [6] analyzed toxic metal
composition of the aerosol as a function of coil temperature and the “age” of a coil in ecigs. In this study, a significant metal loss for iron, chromium, and nickel in the coils was
observed after being heated while dry. The metal loss from the coils may be present in
aerosol inhaled by the e-cigarette user. The coil type, configuration and life span have an
effect on which metals are present and the amount of metal present in the aerosol. Nickel
and chromium, found in e-cig aerosol, are carcinogenic and have been linked to illnesses
such as chronic bronchitis and lung cancer.
Disposable e-cigs (previously known as “1st-generation,” although some modern
disposable e-cigs can take on some properties of subsequent generations) store relatively
little e-liquid, and are inefficient in their nicotine delivery.[7] Other so-called “2ndgeneration” devices are rechargeable, and enable the user to replace or refill cartridges
or “pods,” and permit effective cumulative delivery of nicotine that similar to cigarettes.[8]
“Mod” devices (which may be referred to as “3rd-generation”) offer the most flexibility,
allowing a user to control wattage and temperature in addition to e-liquid composition; the
tanks used in these devices are typically larger, refillable, and sometimes match (or
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exceed) the nicotine delivery profile provided by traditional cigarettes,[9] although some
studies show that 2nd and 3rd generation devices may not always deliver nicotine as
expected.[10, 11]
Higher constant temperature and higher constant wattage conditions are shown to
increase the generation of free radicals [12] and decreases aerosol particle size
distribution.[13] The newest iterations of e-cigs, and the most popular, include those
introduced by the brands Juul, blu, Vuse, and NJOY, and typically rely on replaceable
prefilled pods/cartridges. The e-liquid within these pods/cartridges contains nicotine salts
that are less irritating and deliver nicotine at much higher levels than previous e-cig
generations.[14] Thus, most devices allow users to adjust e-cig use to their preference,
casting further complexity on studies seeking to characterize exposure; two users
operating the same device with the same e-liquid may be exposed to substantially
different toxicant profiles depending on their temperature or power delivery settings.[2]
Thus it is arguably more industrious to investigate ENDS device/liquid combinations
rather than each separately to better evaluate relationships between use and key
outcomes.[3]
The Population Assessment of Tobacco and Health (PATH) study reports that,
among adult ENDS users who used ENDS > 20 days/month, 42.8 % used devices with a
replaceable, prefilled cartridge (e.g., JUUL), 37.0 % used devices with a refillable tank,
10.4 % used a “mod” (modifiable) system, 8.2 % used a disposable device, and 1.6 %
used other e-cig types. It should be noted, however, that there are several limitations to
the PATH study. For instance, rates of use of all products are notably lower in PATH than
in other national-level surveys, possibly due to the method of survey administration (for
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youth, they filled it out in their home possibly in the presence of their parents; for other
national-level surveys, surveys are usually taken in the school). Further, there are issues
with the terms (e.g., ‘cartridge’ rather than ‘pod’) and pictures (the picture of the JUUL
pod is categorized with the pictures of the earlier cig-alikes) used in PATH that likely
influence reporting of device types.[15]

a. Perceptions
The importance of developing and validating absolute and relative e-cig risk
perceptions has been addressed by the scientific field. It was found that beliefs,
perceptions, motives, e-cig use, and dependence were the most commonly assessed ecig related constructs in meta-analyses.[16] In 2022, measures of e-cig health risk
perceptions were streamlined into seven types, including absolute health and addiction
risk, and risk relative to cigarettes, nicotine replacement therapy, and cessation.[17]
Perceived health risks of nicotine and toxins/chemicals in e-cigs significantly differed by
gender, race, sexual orientation, and socioeconomic status. Vu et al. [18] showed that
perceived harm from e-cig product contents were 34% lower in non-Hispanic Blacks
versus non-Hispanic Whites, 33% lower in urban versus suburban residents, 28% lower
in low-income versus high-income families. Lower parental education level was also
associated with lower health risk perception.
The misconception of risks and high availability of e-cigs is highest among
adolescents and young adults.[19] Indeed, a large population of pregnant vapers may
arise from those who initiated e-cig use at a young age and are now addicted. The
Centers for Disease Control and Prevention (CDC) reports that, in 2018, more than 3.6
4

million U.S. middle and high school students used e-cigs in the past 30 days, including
5% of middle school students and 20% of high school students.[20] In meta-analyses of
major data repositories, notably the most recent (2022) Population Assessment of
Tobacco and Health (PATH) Youth survey [21] and another independent review of 184
modified Global Health Youth Surveys[22], it was consistently found that tobacco
cigarettes were perceived as more harmful than e-cigs to health in general, and
pregnancy in particular. An added layer to this is that young adults find e-cigs as a
sociable tool, as they allowed users to align themselves with their peers and facilitated
use within smoke-free environments. Young adults demonstrated high levels of selfefficacy with regards to obtaining e-cigs from various retailers and were active consumers
of e-cigarette marketing.[23-25]
The focus of this dissertation on e-cig exposure during pregnancy is encouraged
by the literature with specific interest in perception of e-cigs within this vulnerable
population, specifically that of tobacco-smoking pregnant women who are motivated to
initiate e-cig use.[26-28] Perceptions of e-cig use during pregnancy comprise several
major themes: (1) e-cigs are safer than traditional cigarettes during pregnancy [29]; (2) ecigs deliver lower amounts of nicotine; (3) e-cigs are a healthier alternative for smoking
cessation aid for pregnant women.[22, 26-28, 30-33]
These perceptions pervade the general population but become a pressing public
health concern when influencing decisions of women about health choices for themselves
and their babies, since there is no sufficient data to support ENDS as a harm reduction
approach during pregnancy.[34-38] Indeed, quality analyses of e-cig research highlight
the lack of an association between e-cigarette use and smoking cessation. Although
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randomized controlled trials (RCTs) tended to support a more positive association
between e-cigarette use and smoking cessation than the cohort studies, the grading of
evidence was consistently low.[39] The e-cig promotion strategies often project them as
“healthier” alternatives or smoking cessation aids.[27, 32] Advertising exposure has been
linked to ever-use of e-cigs in women of childbearing age, including pregnant women.[40]
These claims of safety may influence pregnant women who might have previously
contemplated quitting any form of tobacco smoking for the duration of their pregnancy.[22]
In fact, approximately 69% women of childbearing age perceived e-cigs as a minor or
moderate health hazard, and one out of five women of childbearing age did not believe
that e-cigs posed any health risks.[41] Pregnant women have reported uncertainty about
the health effects of e-cigs and reported attraction towards them as a harm reduction
strategy.[26, 31] Discussions in online forums drew on the premise that immediate
cessation of nicotine (quitting ‘cold turkey’) was potentially harmful and unsafe.[28]. In the
United States, 14-16% percent of pregnant women reported e-cig use during pregnancy,
most commonly to quit smoking.[27, 42] Thus, with the unproven claims of reduced risk
and greater safety associated with e-cig use during pregnancy, understanding potential
harm to the developing fetus is of vital importance.
Ashford et al. [41] conducted a cross-sectional study to assess predictors of ecigarette use among female current and former tobacco users of childbearing age (in a
sample where more than half of study subjects were pregnant). The main finding was that
nearly all current e-cigarette users were dual tobacco users (88%), and nearly half of
current and former e-cig users were pregnant. Most women viewed e-cigs as a minor
(38%) or moderate (31%) health hazard, and younger women were particularly
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susceptible. Mark et al. [43] surveyed over 300 women, finding that ever-e-cig users were
more likely to be current smokers (43% vs. 14%; p<0.001) compared with women who
had never used electronic cigarettes. Knowledge of the harms of smoking was similar
between ever and never users of e-cigs. 43% believed e-cigs to be less harmful to a fetus
than traditional cigarettes. Among ever users, the most common reasons given for the
use of e-cigs were the perception of less harm than traditional cigarettes (74%) and help
with smoking cessation (72%).[43] The 2015 Pregnancy Risk Assessment Monitoring
System (PRAMS) reports that 26.4% of pregnant vapers were unsure of nicotine content,
and a frequently reported reason for e-cig use around the time of pregnancy was curiosity
(54.0%).[44]
Further implications of misconceptions surrounding perinatal e-cig usage could
include combining prenatal exposure with other risky inhalational exposures, notably
prenatal cannabis exposure via e-cigs. Nicotine and cannabis are two of the most
commonly consumed licit and illicit drugs during pregnancy, often consumed together via
e-cigs.[45] Cannabinoids have been found to delay sensorimotor development early in
life, hyperactivity, and impaired motor coordination in early adolescence [46], which aligns
with the focus of behavioral implications of maternal e-cig exposure in this dissertation.

b. Constituents and Toxicology
In toxicology, the dose of a toxicant is vital. Definitions of what constitutes a “dose”
in e-cigs remains an issue in toxicological research. Although puff topography is an area
of high interest, definition of “dose” is still not standardized across studies. Among what
has been proposed or utilized in studies include how much is inhaled, how much is
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deposited in the body, number of puffs, the time course of the puff, number of particles or
number of puffs per unit time.
Due to the absence of combustion of organic matter in conventional tobacco
cigarettes, e-cigs and heated-tobacco-products (HTPs) generate lower number of toxic
substances.[47] However, the number of toxins is not the primary determinant of health
effect, rather exposure dose. It could be argued that e-cigs have a worse acute toxicity
than tobacco; reports of e-cig- or vaping-associated lung injury (EVALI), which leads to
respiratory failure with an intense inflammatory response, go as far back as 2012. In 2019
alone, there was an explosion of cases (2807 confirmed cases in the United States
requiring hospital admission and 68 deaths), while there is no tobacco equivalent of
EVALI. Moreover, long-term e-cig toxicity remains largely uncharacterized.[1] Adverse
health effects related to e-cig aerosols are influenced by several factors, including e-liquid
components, physical device factors, chemical changes related to heating, and health of
the e-cig user.[4]
E-liquids contain nicotine, propylene glycol (PG), vegetable glycerin (VG),
flavorings and other chemicals.[48] Nicotine, one of the main constituents of electronic
cigarettes, is highly addictive and has established neurotoxic effects on the developing
brain, reduced pulmonary function, auditory processing defects, impaired infant
cardiorespiratory function, and may contribute to cognitive and behavioral deficits in
later life.[49, 50] Inhalational nicotine exposure has been linked to generalized stress
responses and activation of the hypothalamic-pituitary-adrenal (HPA) axis, which
involves corticosterone, adrenocorticotropic hormone (ACTH), and corticotrophinreleasing hormone (CRH). Phillips et al.[51] observed decreases in thymus weight, a
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sensitive indicator of systemic stress, in rats following nicotine exposure, as well as
increases in adrenal gland weight.
Propylene glycol (PG) and vegetable glycerin (VG) are the main constituents of
the liquids used to generate aerosols by e-cigs. PG is an aliphatic alcohol used as a
solvent in many pharmaceuticals and flavors and is generally recognized as a safe food
additive. VG is also a food ingredient recognized as safe by the US Food and Drug
Administration (FDA). Although they are components of many ingested compounds and
studied extensively as such, limited data is available on the inhalational toxicity of PG and
VG. One study investigated the toxicology of nebulized PG/VG with and without nicotine
in a 90-day rat inhalation study.[51] Their findings included up-regulation of the xenobiotic
metabolism enzymes Cyp1a1 and Fmo3 and the down-regulation of T-cell-related
transcripts in PG/VG only mixtures (with main effects on lung, liver, and hematopoietic
changes seen only with addition of nicotine). Another study showed ex vivo placental
tissue viability was reduced by >30% at PG/VG concentrations ≥ 10 % (v/v).[52] In mice
exposed to e-cig vapor (free of nicotine) over 4 months, lung lipid homeostasis was
altered in alveolar macrophages and epithelial cells.[53] PG/VG exposed mice also
exhibited immune impairment, notably when challenged with influenza infection, which
led to enhanced lung inflammation and tissue damage. A 3-day exposure to PG/VG
mixture elicited altered tissue elasticity, static compliance, and airway resistance in
mice.[54]
Numerous carcinogens and harmful chemicals like aldehydes, nitrosamines,
metals and polycyclic aromatic hydrocarbons have been isolated in e-cig solutions.[5, 55]
In animal models and in vitro studies, e-cig solution has been found to impair lung growth
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and be cytotoxic to human embryonic stem cells.[56]
Flavoring of e-liquids contributes a large part to e-cig appeal, while also
contributing to the harm potential. Cross-sectional and longitudinal studies suggested that
flavors are important for initiation and continuation of vaping.[57] These flavin-containing
agents are given a GRAS (generally recognized as safe) designation by the FDA and are
widely used in food and cosmetics. While many of these flavoring agents are considered
safe for ingestion, their potential for toxicity when inhaled has only been addressed in a
limited number of studies. For example, diacetyl, used as a flavoring agent in buttered
popcorn, which was found to cause Bronchiolitis Obliterans Syndrome when inhaled by
manufacturing workers.
A significant number of the flavor chemicals are aldehydes, primary irritants of
mucosal tissue of the respiratory tract.[55] Studies have found increased harmful
aldehydes in smoke from flavored e-liquids compared to smoke from unflavored e-liquids.
As many e-liquid flavoring agents are aromatic aldehydes, there is potential for flavored
e-liquids to inhibit Cytochrome P450 2A6 (CYP2A6) activity.[58] CYP2A6, a member of
the cytochrome P450 superfamily of drug-metabolizing enzymes, is responsible for
approximately 80% of the oxidative metabolism of nicotine. This means a reduction of
nicotine metabolism in vivo, which adds further nuance to the toxicity profile of e-cigs.
Toxic degradation products may be produced by reaction of the flavor chemicals at the
high temperatures present during e-cig use. Flavored e-cig products do not typically list
the levels of specific flavor chemicals present, and most do not identify the major flavor
chemicals present.[59] The massive range of appealing flavors may encourage nicotine
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use among never smokers, giving rise to recognition of flavor science and chemosensory
perception as a vital component of contemporary addiction research.[60]

c. Perinatal Toxicology of E-cigs
In the context of this work, the toxicology of e-cigs is crucial as it has perinatal
consequences.[2, 4, 61-63] A pregnant e-cig user introduces the heated and aerosolized
e-liquid to her pulmonary system, which solubilizes the contents of the e-liquid. There are
several hypotheses on the link between pulmonary exposure and systemic effects. One
explanation is the translocation of particles into the blood stream. Subsequently, these
compounds cross the placental barrier, endangering the fetus.
Besides the translocation of nanoparticles, other mechanisms involved may
include inflammatory responses at the placental-fetal interface and beyond, activation of
chemotactic signals and/or alterations in expression of key genes/receptors.[64-66]
Figure 1 demonstrates the maternal, gestational and fetal processes leading to
developmental outcomes following inhalational exposure.[67]
Figure 1-1. Maternal,
gestational, and fetal
processes leading to
developmental outcomes
following inhalational
toxicant exposure. (Adapted
from Stapleton. Gestational
nanomaterial exposures:
microvascular implications
during pregnancy, fetal
development and adulthood.
The Journal of Physiology,
2015)
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Substances remaining on the surfaces in areas where people have vaped
contribute to thirdhand exposure. It has been shown that there is a risk for thirdhand
exposure to nicotine from e-cigs, and thirdhand exposure levels differ depending on the
surface and the e-cig brand.[68] This is important because nicotine left from e-cig
aerosol has been shown to react with oxidizing chemicals in the air to form secondary
pollutants, such as carcinogenic nitrosamines.
Gestation in both humans and rats is divided into three stages-early, mid, and late.
Each stage represents a critical window of embryonic growth, fetal development, and fetal
growth. Maternal inhalational exposure during any of these stages has the potential to
cause adverse health outcomes, and the risks of these outcomes are dependent on the
nature and dose of the toxicant.
In the early stage (commensurate with the 1st trimester in humans), toxicant
exposure could affect placental implantation, fetal organ development, and lasting motor
and cognitive defects in offspring. Toxicants that disrupt placental cell growth, cell
differentiation, angiogenesis, neuronal development and cause oxidative stress affect this
stage more profoundly.[69] For example, heavy metal exposure (a known early stage risk)
has been shown to affect implantation, in addition to accumulating within
umbilical/placental vasculature and embryos (via translocation).[5, 70] Mid-stage (2nd
trimester) gestational exposure affects vascular blood flow and placental development
and function, which negatively impacts the delivery of vital nutrients to the fetus. As the
fetus undergoes significant central nervous system development during this window,
subjection to toxicants could potentially cause postnatal cerebral and cerebellar
dysfunction in offspring, leading to alterations in cognition, memory and behavior.[71-73]
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Late stage (3rd trimester) toxicant exposure may affect vital organ development, fetal
growth, and placental function.[52, 74]
Orzabal, et al. [75] observed that perinatal e-cig exposure caused marked
decrease in blood flow in both the maternal uterine and fetal umbilical circulation (a strong
indicator of growth restriction) leading to a reduction in offspring weight and crown-rump
length.[75] Maternal e-cig use was associated with higher prevalence of low birth weight
[76, 77]and preterm birth, especially among daily users.[76] Prenatal e-cig exposure is
also reported to increase DNA methylation, resulting in lower gene expression.[77]
In a pre-clinical study[78], mouse dams exposed to e-cigs for 4 months exhibited
a significant delay in pregnancy initiation (onset of the first litter), and significantly
impaired embryo implantation (absence of implantation sites despite exhibiting high levels
of progesterone). RNA microarray revealed significant changes in the integrin,
chemokine, and Janus kinus (JAK) signaling pathways, and female offspring exposed to
e-cigs in utero exhibited a significant weight reduction at 8.5 months.[78] Another mouse
model demonstrated significant reductions in hippocampal gene expression of nerve
growth factor receptor (Ngfr) and brain derived neurotrophic factor (BDNF), as well as in
serum levels of cytokines IL-1beta, IL-2, and IL-6 following exposure to e-cig aerosol (with
and without nicotine). The nicotine-free group showed enhanced expression of ionized
calcium binding adaptor molecule 1 (Iba1), a specific marker of microglia, in the
hippocampus.[79]
It has been theorized that exposure of offspring to e-cigs may also be through the
mammary glands, which has implications for women who vape during breastfeeding,
broadening the window for which perinatal e-cig exposure could confer risks.[1] This is
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corroborated by another study which found that a dose of 2 mg/kg/day of nicotine through
placenta and breast milk causes morphological alterations in oocytes in adult offspring,
in addition to mitochondrial changes, embryonic fragmentation, disruption of fetal
development, and fetal malformations suggestive of epigenetic modifications.[80] Further
research is necessary to improve consistency within, and between, clinical and preclinical
findings.

II. Electronic Cigarettes and the Cardiovascular System
Alterations in cardiovascular homeostasis, inflammation, and molecular changes
with e-cig use demonstrate vaping-related cardiovascular health concerns.[81] Indeed,
several in vitro and in vivo studies demonstrate that increased hyperlipidemia,
sympathetic dominance, endothelial dysfunction, DNA damage, macrophage activation,
oxidative stress and inflammation are mechanisms by which e-cig exposure elicits
adverse cardiovascular effects.[82] For example, coronary artery diseases (CAD) is the
world's leading cause of death, and comprises conditions that narrow of the heart
coronary artery lumen due to atherosclerosis.[83] The role of e-cigs in the pathogenesis
of atherosclerosis has been linked to nicotine, propylene glycol, particulate matters, heavy
metals, and flavorings. Here again, molecular mechanisms that are implicated include the
formation

of

reactive

oxygen

species

(ROS),

endothelial

dysfunction,

and

inflammation.[84]
It must be noted that, in some reviews of the literature, an interpretation of “lesser”
cardiopulmonary harm with e-cigs relative to tobacco cigarettes is made when looking at
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certain endpoints. For example, Hajat et al. [85] conclude that switching from cigarettes
to e-cigarettes results in reduced exacerbations of chronic obstructive pulmonary disease
(COPD), and could be beneficial for hypertensive and, by extension, other cardiovascular
patients.[85] Wilson et al. [86] attempted to identify biomarkers with specificity of
association to cardiopulmonary disease (i.e., volatile organic compound (VOCs),
tobacco-specific N´-nitrosamines (TSNAs) and polycyclic aromatic hydrocarbons
(PAHs)).[86] Their findings suggest that, within the limits of these biomarkers, vaping
produces less of these harmful compounds . However, harm will be due to the total toxin
dose, and the authors cede that many known toxicants in e-cig aerosols were
unaccounted for in this study.
Although the FDA has not approved e-cigs as a cessation aid, proponents for ecigs position them as a way for adults trying to quit traditional cigarettes.[87] A limitation
of most clinical studies is the focus on adult e-cig users, who are either smokers or
smokers trying to quit by switching to vaping. Therefore, the cardiovascular
consequences in this population are not attributable to e-cig use alone, which is important
when it is recalled that the novelty and marketing of e-cigs has driven them into the hands
of youth, particularly adolescents.

Role of Oxidative Stress
Cells constantly produce oxidizing species because of their metabolic activity,
which is counteracted by the continuous production of antioxidant species to maintain the
homeostasis of the redox balance. A deviation from the metabolic steady state leads to a
condition of oxidative stress. The source of oxidative species can be endogenous or
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exogenous. Reactive oxygen species (ROS) are products of the body's incomplete
reduction of oxygen molecules. They oxidize fats, proteins, and DNA and thus can
contribute to tissue damage. Toxic oxidation reaction products exert a cytostatic effect on
the cell, damage cell membranes, and activate mechanisms of apoptosis.[88] ROS refers
to a group of oxygen-derived molecules, including radicals such as superoxide anions
(O2.-), hydroxyl anions, and hydrogen peroxide (H2O2), that influence vascular tone.
Several enzymes are involved in the generation and inactivation of ROS.[61, 8991] Superoxide anion (O2·-) can be produced in the vascular wall by NADPH (reduced
form of nicotinamide adenine dinucleotide phosphate) oxidases (Nox1 and Nox2),
xanthine oxidase, uncoupled endothelial nitric oxide synthase (eNOS), and the
mitochondrial respiration chain. O2·- can be converted to hydrogen peroxide (H2O2) by
the enzyme superoxide dismutase (SOD). H2O2 can undergo spontaneous conversion
to hydroxyl radical (OH·). OH· is extremely reactive and attacks most cellular
components. H2O2 can be detoxified via glutathione (GSH) peroxidase, catalase or
thioredoxin (Trx) peroxidase to H2O and O2. The enzyme myeloperoxidase can use
H2O2 to oxidize chloride to the strong-oxidizing agent hypochlorous acid (HOCl). HOCl
can chlorinate and thereby inactivate various biomolecules including lipoproteins and the
eNOS substrate l-arginine. Besides HOCl generation, myelo-peroxidase can oxidize (and
thus inactivate) NO to nitrite (NO2−) in the vasculature.[91]
Xanthine oxidoreductase (XOR) is a term describing both xanthine dehydrogenase
(mostly intracellular) and xanthine oxidase (mostly extracellular). XOR catalyzes the
oxidation of hypoxanthine to xanthine to uric acid (reducing NAD+ to NADH), producing
ROS on the vascular endothelium intracellularly (and subsequent endothelial
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dysfunction), and generating O2.-and H2O2 extracellularly. Acute inhibition of oxidative
stress with TEMPOL (a free radical scavenger) or Febuxostat (inhibitor of xanthine
oxidase) is a way to determine the involvement of these specific pathways if restoration
of vessel impairment is observed.
Excessive generation of ROS has been widely viewed to play a critical role in
cigarette smoke-related CVD. Likewise, ROS overproduction and molecular initiating
events has the potential to play a role in e-cig-related cardiovascular toxicity and
injury.[61] Modified risk tobacco product use, including e-cigs, have been shown disrupt
the balance between pro-oxidant pathways and antioxidant pathways, leading to systemic
oxidative stress, via direct exposure.[92]
At high powers, ROS emissions in e-cigs matched that of combustible cigarettes
and were highly correlated with power per unit area.[93] Further, an increase in the VG
percentage in the liquid yielded higher ROS flux, and nicotine did not affect ROS
emissions. ROS emissions are a function of device design and liquid composition at a
given power. Importantly, ROS formation is significant even when the e-liquid consists of
purely of PG and VG. Zhao et al. [89] confirmed ROS generation in cellular and acellular
systems, which was highly dependent on the e-cig brand, flavor, puffing pattern and
voltage. In this study, H2O2 accounted for 12-68% of total ROS.
Chatterjee et al. [94] evaluated the acute response to aerosol inhalation of nonnicotinized e-cigs in terms of oxidative stress, immune cell adhesion and indices of
endothelial activation in human pulmonary microvascular endothelial cells (HPMVEC).
Ten smoking-naïve healthy subjects were subjected to an e-cig challenge, following which
their serum was monitored for markers of inflammation [C-reactive protein (CRP) and
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soluble intercellular adhesion molecule (sICAM)] and nitric oxide metabolites (NOx).
Serum indices of oxidative stress and inflammation increased, reaching a peak at
approximately 1-2 h post-e-cig aerosol inhalation, while the circulatory burden of the
serum (ICAM-1 and ROS) increased significantly at 2 h. Values returned to baseline after
6 hours. ROS production by HPMVEC was found to occur via activation of the NADPH
oxidase 2 (NOX2) pathways. Lee et al. [95] demonstrated that, in human pluripotent stem
cell derived endothelial cells, cinnamon-flavored e-cig products were the most cytotoxic,
leading to significantly decreased cell viability, increased ROS, caspase 3/7 activity, and
low-density lipoprotein uptake, activation of oxidative stress-related pathways, and
impaired tube formation and migration, confirming endothelial dysfunction. Moreover,
macrophage polarization led to a pro-inflammatory state, eliciting the production of
interleukin-1β and -6.
Another study demonstrated that the endothelial dysfunction through excessive
ROS production from e-cig exposure was a result of decreased nitric oxide (NO)
bioavailability, increased endothelial cell apoptosis, and impairment in angiogenesis and
wound healing, especially in diabetes.[96] Indeed, NO bioavailability is susceptible to
accumulations of ROS, leading to impaired vasodilatory response.[97]
Under physiological conditions, eNOS produces NO, which represents a key
vasoprotective factor of the endothelium. Under pathological conditions associated with
oxidative stress, however, eNOS may become dysfunctional. Oxidative stress contributes
to endothelial dysfunction primarily because of rapid oxidative inactivation of NO by
excess superoxide. Persisting oxidative stress renders eNOS uncoupled (i.e., uncoupling
of O2 reduction from NO synthesis), such that it produces superoxide at the expense of
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NO. Mechanistically, deficiency of eNOS cofactor tetrahydrobiopterin (BH4), deficiency
of eNOS substrate l-arginine, and eNOS S-glutathionylation are likely to be the major
causes for eNOS uncoupling. Peroxynitrite and superoxide can oxidize BH4 leading to
BH4 deficiency. ROS production from uncoupled eNOS has been shown in rodent models
of atherosclerosis, hypertension, and in chronic smokers.[91]
This pathway is thought to be key in how e-cigs may cause cardiovascular
dysfunction.[98] L-NG-nitroarginine methyl ester (LNAME) is an NO inhibitor. In vascular
studies, incubation of vessels with LNAME demonstrates the contribution of NO
involvement in vasodilatory responses.
Taken together, there is evidence that direct e-cig exposure through various routes
has the potential to drive the onset of vascular pathologies via oxidative stress pathways.

III. Electronic Cigarette Use and Behavior
Few studies have looked at behavioral outcomes in offspring who received e-cig
exposure in utero. In a study of nicotine-containing e-cig exposure during late prenatal
and early postnatal life (a period of rapid brain growth), Smith, et al. [99] found that adult
male mice (who received late prenatal/early infancy exposure to e-cigs) exhibited
increased levels of activity in the zero maze and open field tests (rearing). In another
mouse model [100], the findings showed deficits in short-term memory, reduced anxiety,
and hyperactivity in offspring following maternal e-cigarette exposure using the novel
object recognition and elevated plus maze tests. In addition, global DNA methylation was
increased in the brains of offspring soon after birth, with 13 key genes identified to be
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significantly altered from the e-cig groups compared to the nonexposed groups.
Nicotine from e-cigs may exert unique effects on specific brain regions during
distinct developmental periods due to the dynamic expression of nicotinic acetylcholine
receptors (nAChRs) throughout the lifespan. Thus, nicotine exposure could have
neurotoxic effects on the fetus, newborn, child, and adolescent.[101] Additionally,
prenatal nicotine exposure leads to behavioral outcomes that are typically sexdependent.[102]
There is evidence that attention deficit hyperactivity disorder (ADHD) is associated
with prenatal nicotine exposure.[103] A possible mechanism for this stems from the fact
that developmental nicotine exposure has been established to elicit brain-derived
neurotrophic factor (BDNF) deficits and hypothalamic-pituitary-adrenal (HPA) axis. This
dysregulation is characteristic of neurodevelopmental disorders such as ADHD, autism,
and schizophrenia.[104]

Other Prenatal Risk Factors Affecting Neurocognitive Development
Maternal health is closely associated with cognitive outcomes in offspring. Several
maternal exposures during pregnancy are considered predisposing factors for offspring
neurodevelopmental conditions, especially if inflammation is a predominant feature.[105]
Early nutrition via the mother is linked to epigenetic processes and cognitive
performance. For example, a high-energy diet (e.g., increased fructose intake[106]),
enhances anxiety-related behavior in offspring and impairs learning and memory.[107] A
maternal high-fat diet can affect offspring neurodevelopment due to inflammatory
activation of the maternal gut, adipose tissue, and placenta, mirrored by increased levels
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of pro-inflammatory cytokines in both maternal and fetal circulation.[108] These changes
may be mediated by epigenetic modifications including the downregulation of BDNF
expression, activation of the endocannabinoid system, and/or alterations in N-methyl-Daspartate (NMDA) receptor expression.[109] Almond consumption during pregnancy
could exert neuroprotective effects and improve anxiety, short-term memory, stress
adaptation, and cognitive performance in adult offspring.[110] Maternal nutritional
deficiency due to hyperemesis gravidarum is associated with smaller cortical volumes,
leading to neurodevelopmental and mental health disorders.[111]
Drug use during pregnancy is established as a risk factor for neurobehavioral
deficits. Prenatal methamphetamine exposure, for instance, negatively impacts cognitive
performance in prepubertal male and female rats via impairment of hippocampal synaptic
functions[112] Similarly, prenatal methadone (an opioid) exposure affects adult offspring
hippocampal function, leading to learning and working spatial memory impairments.[113]
Cannabis smoke and Delta(9)-THC are developmental toxicants observed to elicit
changes in motor behavior, cognitive performance, emotionality and susceptibility to drug
sensitivity later in life.[114] During pregnancy, women are prone to depression, for which
fluoxetine (a selective serotonin reuptake inhibitors, SSRIs) is usually the first-line
treatment. However, fluoxetine can cross the placental barrier and changes serotonin
levels early in life which impairs the basal state of anxiety and the cognitive functions of
rats during adulthood.[115]
Distressing events during pregnancy that engage activity of the body's endocrine
stress response have been linked with later life cognitive deficits in offspring. Interestingly,
prenatal stress (PS)-induced alterations have shown some sex specificity. Anxiogenic
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behaviors, anhedonia, and female HPA axis hyperactivity was observed as a
consequence of psychosocial PS in mice.[116] The connectivity between the HPA axis
and the hippocampus and the density of glucocorticoid receptors (GRs) in the
hippocampus suggests this structure modulates activity in the stress circuitry in a sexspecific pattern.[117] Chronic psychological stress in pregnant rats was found to impair
spatial learning and memory ability of offspring, by disturbing the nitric oxide (NO)-cyclic
guanosine monophosphate (cGMP)-protein kinase G (PKG) (NO/cGMP/PKG) signaling
pathway.[118] Maternal prenatal emotional symptoms have been associated with
alterations in the offspring meconium microbiota and children's neurodevelopment at 24
months of age.[119]
It is important to note that genetic liability to neurodevelopmental conditions that is
passed from mothers to children was associated with several pregnancy-related factors
and may therefore confound associations between these pregnancy-related factors and
offspring neurodevelopment that have previously been thought to be causal.[72]

Justification of the rat model
Human subject research may prove challenging, invasive, and/or unfeasible in
assessing effects of e-cig exposure, especially when dealing with perinatal studies. This
is in part due to the time course of a human versus a rodent pregnancy. Human perinatal
studies would require an extensive timeline to study effects during pregnancy (9 months
compared to 21 days in rats) and even longer to study offspring effects into adolescence
and adulthood. For this reason, animal models are often employed. Rodents have
historically been the preferred animal model for biomedical research due to genetic and
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physiological similarities to humans. From a physiological standpoint, more is known
about the responses and pathways in rats than in other species due to the wealth of data
collected over the years. Moreover, for over a century, the rat has been favored for
studying neurobiological processes and for providing neuropsychological models for
human behavioral disorders; due in part to its complex behavioral repertoire.[120] Rats
have a number of clear advantages, such as the relatively large size of their brains and
they are much easier to handle than mice and less easily stressed by human contact (less
risk of confounding due to animal stress).[121]

IV.

Summary and Statement of Aims
The central hypothesis of this dissertation is that maternal e-cig exposure during

pregnancy affects vascular and behavioral outcomes in the offspring. The overall aim of
this work is to further our understanding of potential life-long risks in offspring associated
with vaping during the vulnerable state of pregnancy and help inform healthcare providers
and policymakers to improve antenatal and preventative care in the face of this growing
epidemic.
The first specific aim was to determine dose-dependence and longevity of effects
of maternal e-cig aerosol exposure (with and without nicotine) on arterial stiffness and
vascular reactivity in offspring across two vascular beds. Chapter 2 aims to evaluate
these vascular changes in conduit vessels at two time points in offspring life- 3 months
and 7 months (representing adolescent and adult life, respectively) using either a 20-puff
or 60-puff per hour per day e-cig exposure. Chapter 3 focuses on resistance vessels in
the brain; the middle cerebral arteries of 1-, 3- and 7-month-old offspring were evaluated
23

for changes in vascular reactivity at the lower, 20-puff/day condition. These chapters also
aim to investigate potential mechanisms involved in the observed vascular dysfunction.
The second specific aim of this dissertation was to evaluate the implications of
perinatal maternal e-cig use on cognitive function in the progeny. Chapter 4 aims to
characterize cognitive dysfunction and behavioral changes in early life of exposed pups
by testing their spatial/aversive learning and short- and long-term memory using the 20vs 60-puff paradigm.
Taken together, the data would provide insight into long-term detrimental effects
of maternal e-cig exposure during gestation and lactation on vascular and behavior health
of offspring.
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ABSTRACT
Vaping, or electronic cigarette (ecig) use, is prevalent among pregnant women,
although little is known about the effects of perinatal ecig use on cardiovascular health of
the progeny (even when using nicotine-free e-liquid). Maternal toxicant inhalation may
adversely affect vital conduit vessel development. We tested the hypothesis that perinatal
exposure to maternal vaping would lead to a dose-dependent dysfunction that would
persist into later life of offspring. Pregnant Sprague-Dawley rats were exposed to either
nicotine-free (Ecig0) or nicotine-containing Ecig aerosol (18 mg/ml, Ecig18) starting on
gestational day 2 and continued until pups were weaned (postnatal day 21). Pups were
never directly exposed. Conduit artery function (stiffness and reactivity) and structure was
assessed in 3- and 7-month old offspring. At 3-months, pulse wave velocity (PWV) in the
ecig0 and ecig18 offspring were significantly higher than controls in both the 20-puff/day
(6.6±2.1 and 4.8±1.3 vs. 3.2±0.7 m/s, respectively, p<0.05, mean ± SD) and as 60puff/day exposure cohort (7.5 ± 2.8 and 7.5 ± 2.5 vs 3.2 ± 0.5 m/s, respectively, p<0.01).
Wire myography revealed (range of 23-31%) impaired aortic relaxation in all ecig
exposure groups (with or without nicotine). Incubation of vessels with TEMPOL or
Febuxostat reversed the aortic dysfunction, implicating involvement of reactive oxygen
species. Nearly identical changes and pattern was seen in vascular outcomes of 7-month
old offspring. The take home message from this pre-clinical study is that maternal vaping
during pregnancy, with or without nicotine, leads to maladaptations in vascular (aortic)
development that persist into adult life of offspring.
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GRAPHICAL ABSTRACT

NEW & NOTEWORTHY
We observe a significant alteration in arterial structure and function in adolescent
and adult offspring due to developmental exposure to toxicants resulting from perinatal
maternal vaping. Taken together with previous work that described lasting dysfunction in
cerebral microvasculature in offspring, these data underscore the adverse consequences
of maternal exposure to electronic cigarette aerosol in conduit and resistance vessels
alike, irrespective of nicotine content.
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INTRODUCTION
Electronic cigarette (ecig) use, or vaping, is increasingly prevalent among pregnant
women, ranging between 5-15% of the surveyed pregnant population within the last five
years (1-5). Pregnant women who have a history of smoking conventional tobacco
cigarettes are attracted to ecigs for fear of harming their unborn baby from the widely
accepted dangers of smoking, which include preterm birth, intrauterine growth restriction,
and sudden infant death syndrome. Indeed, the perception that ‘vaping is safer than
smoking’ pervades forums for pregnant women (1, 6-9). However, emerging reports on
adverse health effects of vaping on the maternal-fetal dyad indicate there are many
reasons for concern, which include adverse developmental outcomes due to disruptions
in placental function (10-14), impaired brain glucose utilization (15), altered lung
organogenesis, remodeling and function (16, 17), liver dysfunction (18), epigenetic
changes (19, 20), and cardiovascular deficits (11, 12, 14, 21).
Nicotine addiction is the primary driver of smoking or vaping during pregnancy, and
regardless of intrinsic factors (e.g., age, smoking history) or delivery vehicle (e.g.,
cigarettes or ecigs), the consequences of perinatal nicotine exposure on the growth and
development of the fetus are numerous and well-described (see reviews (22, 23)). Unlike
cigarettes, the ability to use ecigs without nicotine provides a unique opportunity to
evaluate pregnancy exposure on health outcomes of offspring to e-liquid solution in the
absence of nicotine. Although humans are unlikely to vape without nicotine, we (24) and
others (25-27) have exploited this experimental capability and find that vaping without
nicotine induces similar microvascular dysfunction as vaping with nicotine. Thus, the
reproductive toxicological impact of ecigs are only just beginning to be studied and
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realized.
In humans (28, 29) and animals (30, 31), smoking and vaping have been reported
to increase arterial stiffness and endothelial dysfunction, both of which are prodromic for
cardiovascular disease. Endothelial cells play a critical role in cardiovascular homeostasis
by regulating vascular tone, angiogenesis and adhesion/aggregation of cells in
circulation. Endothelial dysfunction and arterial stiffness are positively associated with
hypertension, coronary artery disease, stroke, heart failure and arrhythmias. Moreover,
maternal factors such as nutrition status, obesity, hypertensive pregnancy or essential
hypertension, diabetes, alcohol intake and uteroplacental insufficiency have been
associated with increased arterial stiffness in offspring, but the effects of maternal vaping
during pregnancy on gestational disruptions to large vessel development is yet to be fully
understood. Given that even low levels of smoking, and exposure to ambient air pollution,
are known to significantly increase cardiovascular risk (see review (32)) and adversely
influence pregnancy outcomes (see review (33)), understanding the risks from electronic
cigarettes is of great public health importance.
The objective of this study was to evaluate maternal vaping exposure during
pregnancy (with and without nicotine) on large conduit artery structure and function in
adolescent and adult offspring with perinatal exposure. We tested the hypothesis that
perinatal exposure of progeny to maternal vaping would alter vascular development and
lead to a dose-dependent dysfunction that would persist into adolescent- and adult-life of
offspring.

MATERIALS AND METHODS
Animal breeding and maternal exposure conditions
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All procedures were approved by the West Virginia University Animal Care and
Use Committee. Timed pregnancies were achieved by breeding male (250-275 grams)
and female (200-250 grams) Sprague Dawley rats (Charles River, Wilmington, MA) in a
pathogen-free vivarium facility at West Virginia University. Standard rat chow and tap
water were provided to dams and offspring, and animals were kept on 12:12 day: night
cycle during the study. Determination of pregnancy and gestational day (GD)-0 was made
with the observation of sperm and/or vaginal plug on the female. Rats were then randomly
assigned to: 1) ambient air (control, n=5), 2) Ecig liquid with no nicotine (ecig0, n=5), or
3) Ecig liquid with 18 mg/ml e-liquid nicotine (ecig18, n=5)(Table 1). E-liquid used for both
vape exposure consisted of 75/25 vegetable glyercin:propylene glycol (VG:PG)
composition with French Vanilla flavor and was obtained from a local vape shop. Up to
2 pregnant dams experiencing the same exposure were housed together until giving birth
(i.e. GD20).
Maternal exposure began on GD2 using a whole-body exposure (InExpose, Scireq
Inc., Montreal, Canada). After birth, exposure to dams (not pups) continued during the
weaning period until postnatal day 21 (PD21). Pups were never directly exposed to ecig
aerosol. Ecig0 and ecig18 exposures were performed concurrently using two separate
but identical ecig devices and exposure chambers that were independently operated and
monitored. Control (air exposed) dams were handled and transported daily in similar
fashion to exposed dams. Our maternal exposure was limited to the window of gestation
and lactation to provide a direct assessment of vaping during the perinatal period only,
and to eliminate any potential feed-forward effects that might occur with vaping
experiences prior to becoming pregnant. Although this design is not strictly mimicking the
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human condition (i.e., who likely would be smoking or vaping prior to becoming pregnant),
it does provide direct experimental evidence toward the consequences of vaping solely
while pregnant. Pups were never directly exposed, but co-habited with dams (when dams
were not being exposed to vape aerosol) until weaning.
Maternal exposure was conducted for 1 hour/day, 5 days/week. For dose effect
determination, frequency of ecig activation was increased three-fold between the ecig
cohorts. The first cohort of dams was administered 1-puff every 3 minutes for 60 minutes
(i.e., 20-puffs in 1 hour) of either ecig0 or ecig18, while the second cohort received 1-puff
every minute for 60 minutes (i.e. 60-puffs in 1 hour). We used identical tank-style,”mod”
ecig devices purchased online (Joyetech eGrip OLED). The Ecig device was controlled
by an external computer-activated solenoid in a custom-cradle (to hold the Ecig device)
which allowed precise and reliable triggering of the Ecig device without any modification
to the device itself. Ecig puff duration was set to 5-sec and with watts set at 17.5W. An
inhalation draw of ~1 lpm was generated by the computer-controlled exposure system
and a continuous bias flow of 5 lpm of air was flushed in to the chambers throughout the
exposure. This resulted in an intermittent (i.e. saw-tooth) exposure pattern to the Ecig
aerosol that more closely mimics human vaping patterns compared to traditional wholebody chamber environments. Atomizers were changed once a week.

Aerosol Analysis
We have previously reported the concentration and size of the aerosol particles
produced for maternal exposures in this study (24). In brief, concentration and size of the
aerosol particles were analyzed separately using condensation particle counters (CPC
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Model #3775, TSI Inc.) and an electrical low pressure impactor (ELPI+, Dekati Ltd),
respectively. Assessment of the vape cloud showed a complex, but similar distribution
pattern between the respective devices/chambers, resulting in a median particle diameter
of 0.395 μm and 0.336 μm for E-cig0 and E-cig18, respectively. Control conditions
showed very wide and negligible detection of particles in ambient air.

Vascular Assessments:
At the appropriate study group age (3- and 7-months), vascular stiffness was first
assessed using in vivo ultrasonography for pulse wave velocity (PWV), after which ex
vivo aorta structure and function were assessed (details provided below).
In vivo ultrasonography: PWV provides an indirect measure of arterial stiffness
(with stiffer vessels having higher PWV) and is useful for characterizing cardiovascular
disease and progression. Under sedation (isoflurane, 5% induction, 2-3% maintenance),
left common carotid arteries (LCCA) were noninvasively imaged using Vevo2100 highfrequency microultrasound (VisualSonics Inc, Toronto, ON, Canada). Doppler ultrasound
images and ECG signal detection were saved for offline analysis using VisualSonics
analysis software. Distance (d) between proximal (downstream to aortic arch) and distal
(upstream of bifurcation) points on the LCCA were measured, as well as the arrival time
of pulse wave upstroke relative to R-wave peak (t). Repeated (≥3) measurements for
each variable were averaged. Pulse-wave velocity was calculated using the regional
transit-time (TT) method (PWV=Δd/Δt). We choose to evaluate PWV in the carotid artery
since the distance between proximal and distal points can reliability be measured in a

47

single image, and that ageing effects on PWV in the carotid artery closely mirror that in
the aorta (34).
Ex vivo aorta structure and function: Offspring were anesthetized and blood
pressure (via tail cuff plethysmography, Kent Scientific), body temperature and heart rate
were also assessed and recorded. Thereafter, rats were euthanized by exsanguination
using phosphate-buffered solution (PBS) to flush the vascular system of blood via
intracardiac (left ventricle) puncture. Thoracic aorta was excised and placed in ice cold
buffer solution to be used for wire myography experiments (described below), while
abdominal aorta was preserved in 10% neutral buffered formalin and paraffin-embedded
for histological analysis.
Freshly excised thoracic aorta were carefully cleaned of surrounding adipose
tissue and cut into 2mm rings. The aortic rings were immediately mounted on a 4-chamber
wire myograph system (DMT, ADInstruments) containing warm aerated (37°C; 95%
O2 and 5% CO2) Krebs-Henseleit buffer solution (1.18 mM KH2PO4, 1.2 mM
MgSO4•7H2O, 4.7 mM KCl, 25 mM NaHCO3, 118 mM NaCl, 5.5 mM glucose, 0.026 mM
Ethylenediaminetetraacetic acid (EDTA). Following a 1-hr equilibration and gradual 2g
preload tension, the vessels were challenged with KCl to confirm viability and determine
maximum constrictor response. After wash-out and preconstriction with thromboxane A2
mimetic U-46619 (U46; 10-8M), the vessels were subjected to methacholine (Mch;10-9M
to 10-4M) to assess endothelial-dependent relaxation. Vessel rings were washed 3x and
methacholine concentration-response curves were repeated following a 30-minute
incubation with either: (1) nitro-L-argininemethylester, L-NAME (a nitric oxide synthase
inhibitor, 10-5M), (2) TEMPOL (superoxide dismutase mimetic,10 -5M) or (3) febuxostat
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(xanthine

oxidase

inhibitor,

10-10M).

For

endothelial-independent

relaxation,

preconstricted vessels were challenged with sodium nitroprusside (SNP, NO donor;10-9M
to 10-5M). Finally, cumulative concentration-response with constrictor U46619 (U46;1012M

to 10-8M) was reported as a percentage of KCl standard response.
For histologic assessment, 5 µm sections of the aorta were deparaffinized and

stained with Verhoeff-Van Gieson for elastin fibers (Sigma-Aldrich) or Masson’s trichrome
(Sigma-Aldrich) for collagen fibers. ImageJ (Fiji) software was used to calculate the total
area of aorta and quantify elastin and collagen content. Relative densities of elastin and
collagen fibers were calculated and reported as percent of the aorta section area.

Body Composition Analyses
Lean and fat body mass were measured at weaning (PND21-23) and at 7-months
of age. At weaning, we used EchoMRI system (Model 500, EchoMRI LLC, Houston, TX)
in alive unanesthesized rats to assess body composition. At 7-months of age, we used
Dual x-ray absorptiometry (DEXA, Model 8056 Discovery-SL) calibrated with rat phantom
to assess body composition in isoflurane-anesthetized rats. All measurements were made
according to manufacturer’s guidelines and instructions for animal body composition
testing for each apparatus.

Data and Statistical Analyses
All data are expressed as mean±SEM. Two-way analysis of variance was used to
identify main-effects for dose (20- vs 60-puff) and exposure condition (air vs ecig0 vs
ecig18). One-way analyses of variance (ANOVA) tests were conducted for dependent
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variables to address comparisons with exposure groups; and where appropriate,
repeated measures ANOVA was used for comparison of multiple measurements within
the same animal. For significant main effects, effect sizes were calculated using GPower
3.1 software, using “ANOVA: Fixed effects, omnibus, one-way” to report f values. Tukey’s
post-hoc tests were done in instances of significant main effect in ANOVA. In all cases,
p≤0.05 was taken to reflect statistical significance.

RESULTS

Maternal Exposures
Table 1 summarizes chamber exposure conditions, litter characteristics and
anthropometric/clinical measures of offspring. Litter size and body mass at birth were not
different between groups. At weaning, ecig0 pups have significantly higher body fat (BF)
mass and lower lean body mass (LBM) than controls (Table 1). At 7-months of age, body
mass was not different between any of the groups, but 20-puff ecig exposed offspring
show lower BF and higher LBM (p<0.05). 60-puff exposure shows high BF and lower LBM
with ecig0 (p<0.05), but not ecig18.

Arterial stiffness and histology
Pulse wave velocity (PWV) was significantly greater in 3–month old ecig0 and
ecig18 offspring compared to air (effect size f=2.978, p<0.05 ANOVA) (Figure 1). The
increase in carotid PWV (i.e., stiffness) was not dose-dependent to the number of
maternal puffs (i.e., 20- vs 60-puff) exposure and not different based on presence or
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absence of nicotine (i.e., ecig0 vs ecig18) (Figure 1). PWV at 7-months trends toward the
same pattern (p=0.057 ANOVA). No significant Exposure by Puff interactions were
observed.
We also assessed potential structural changes or adaptations in the aorta of
offspring by selectively staining for elastin and collagen (Figure 2A). We observed a
significant reduction in elastin (ANOVA p<0.001) coupled with increase in collagen
(ANOVA p<0.001) under all vape conditions compared to controls (Figure 2A & B).
Examination of the elastin:collagen (E:C) ratio reveals a range of 41-54% decline in E:C
ratio compared to controls (effect size f=1.262, ANOVA p<0.001 Figure 2C), which is
consistent with a stiffer vessel wall. All ecig exposed groups, regardless of age, ecig dose
or nicotine, exhibit significant E:C decline compared to air-exposed controls (Figure 2C),
i.e., no significant Exposure by Puff interactions were observed.

Aorta reactivity and function
Aortic reactivity to increasing doses of methacholine (MCh) was assessed (Figures
2 & 3). At 3-months of age, nicotine vs no nicotine (ecig0 and ecig18, respectively) groups
showed similar impaired endothelial-dependent responses to MCh-induced relaxation
compared to control offspring (with a 24±2% average reduction in aortic reactivity
compared to controls, ANOVA p<0.01, effect size f=9.703, Figure 3A & B). Impaired
MCh-induced relaxation was not different in offspring with maternal exposure to 20 vs 60
puffs, where reductions in maximal MCh reactivity was 24±5% and 22±4% for ecig0 and
ecig18, respectively (for 20-puff cohort); and 25±2% and 26±3% in ecig0 and ecig18,
respectively (for 60-puff cohort). Endothelial-independent reactivity to SNP (Figure 4A)

51

and increased constriction tension to U44619 (Figure 4B) were not different between
groups.
At 7-months of age, we observed similar levels and patterns of impairment in aortic
reactivity in the offspring noted at 3-months of age, with a 24±3% average reduction in
aortic relaxation compared to controls, p<0.01, Figure 3C and 3D). The impaired
relaxation was not different in offspring between maternal exposure to 20- vs 60-puffs,
where reductions in maximal relaxation were 20±2% and 28±7% for ecig0 and ecig18,
respectively (for 20-puff cohort); and 21±3% and 26±4% in ecig0 and ecig18, respectively
(for 60-puff cohort). As before, there were no differences with respect to nicotine, no
significant Exposure by Puff interactions were observed. and the endothelial-independent
reactivity to SNP (Figure 4C) and the vasoconstriction responses to U46619 (Figure 4D)
were not different between groups.

NO bioavailability and Oxidative Stress
Using L-NG-Nitro arginine methyl ester (L-NAME) we observed that aortic
relaxation was nearly abolished in all groups (Figure 5), suggesting NO bioavailability as
a key mechanism for aortic dysfunction. The fact we observed that all vaping conditions
(ecig0 vs ecig18, 20 vs 60 puffs) equally impaired aortic reactivity (by ~ 14%)
demonstrates the importance of NO in this response and suggests that reduced NO
bioavailability is not due to nicotine (or least, not at this nicotine dose).
Next, we explored the role of oxidative stress on aortic EDD with acute coincubation of aorta with Tempol (a superoxide dismutase mimetic) and Febuxostat (a
selective inhibitor of xanthine oxidase). Tempol has no effect on EDD in air group (as
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expected), but Tempol was effective in restoring the impaired maximal EDD for all vape
conditions (Figure 5). Likewise, we found that Febuxostat was equally effective in
restoring the impaired maximal EDD for all the vaping conditions (Figure 5). Taken
together these data suggest the ROS-induced reductions of endothelial cell-mediated NO
exerts a critical influence on the vascular dysfunction observed.

DISCUSSION
Epidemiological, clinical and experimental data show that pregnancy and early life
are critical sensitive windows of susceptibility and that periconceptional, perinatal and
postnatal environments can have significant influence on offspring’s risk for later-life
chronic disease (35). In this study we describe consequences of maternal ecig exposure
on central arterial stiffness and aortic reactivity in the F1 adolescent- and adult-age
progeny. The results of this study extend our previous work (showing vascular dysfunction
in the middle cerebral artery, a resistance vessel)(24) to health risks toward central
conducting vessels (i.e., aorta and carotid arteries). In offspring that have only received
perinatal exposure to ecig aerosol, we observe 2-3 fold increase in carotid artery stiffness
and ~20-30% deficit in aortic reactivity compared to controls. Increasing maternal
exposure three-fold (from 20- to 60-puffs/hour) in our paradigm did not create a dosedependent effect on the progeny’s vascular outcomes. Likewise, the presence or absence
of nicotine in the e-liquid did not significantly alter the deficits observed within any of the
ecig exposed offspring. Notably the changes is arterial stiffness and endothelial
dysfunction were observed in adolescent (3-month old) offspring persisted into adult life
(7-months of age).
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Arterial stiffness and aortic dysfunction
Increased arterial stiffness and vascular dysfunction (e.g. flow-mediated dilation)
are reported with direct ecig exposure in humans (36) and animals (30, 37). Our finding
of elevated PWV in 7-month-old animals without direct exposure to ecig aerosol (and only
perinatal exposure from maternal vaping) suggest a developmental and/or epigenetic
mechanism(s) producing the dysfunction we observed in response to maternal exposure
during pregnancy. The observation of increased arterial stiffness is significant because
vessel stiffness is an independent predictor of cardiovascular disease and is associated
with worsening ventricular-vascular coupling (38). Prior research has also shown that
infant aortic PWV may be a useful index that is sensitive to the gestational environment
(39), which is consistent our finding that offspring up to 7-months old have increased
arterial stiffness with only perinatal exposure. It is important to note greater arterial
stiffness is seen in offspring of parents with hypertension and is an early prognostic
indicator in the pathogenesis of hypertension (40). Indeed, elevated blood pressure alone
can also increase PWV, thus it is critical to know the underlying hemodynamic status (e.g.
blood pressure) when evaluating our data. We measured blood pressure (using tail-cuff
method, Table 1) and did not find significant differences between our groups, but
admittedly this method is a peripheral measure and does not exclude the possibility the
central blood pressure could have been elevated. Given that histological assessment
show that there were intrinsic or structural changes in the vessels in offspring with
perinatal exposure (i.e., reductions in the E:C ratio in aorta, Fig. 2), which is consistent
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with elevated arterial stiffness, it tempting to speculate the effects we see may be a
precursor to hypertension in the offspring.
It is interesting to note that the dose effect for maternal exposure we used (i.e. 20vs 60-puffs) did not result in significant differences in the vascular outcomes we reported.
This could be because 3-fold greater number of puffs (with all other settings staying the
same) did not significantly change the total (or average) aerosol density in the exposure
chamber (Table 1). So even though the 60-puff regime did tend to produce greater
number of particles, our exposure paradigm was designed to quickly flush the chamber
with clean air (after each puff). This allowed us to expose the dams to an intermittent
exposure and allowing some clear air breaths between each puff, which is more similar
to human use (rather than a constant and continuous exposure often achieve with whole
body exposures). We would also emphasize, similar vascular impairment between 20vs. 60-puff exposures suggests the threshold for vascular dysfunction ensuing from
vaping is likely to be quite low. One important interpretation from this is that a reduction
in exposure by reducing the number puffs by pregnant users (who might resolve to cut
back on their vaping habit during pregnancy) may not be successful in preventing harm
or risks to their offspring. Given that 20 puffs/day is relatively low (particularly in terms of
human behavior/use), there may be no safe level of exposure during pregnancy.

Endothelial dysfunction and oxidative stress
Endothelial dysfunction is widely recognized as a pre-clinical risk factor for
cardiovascular and cerebrovascular disease and is linked to an imbalance between
endothelium-derived relaxing and/or contracting factors (e.g., reduction in the

55

bioavailability of nitric oxide, NO). Both smoking (41) and vaping (42) are found to reduce
NO bioavailability, which is consistent with our observation that MCh stimulation with LNAME reduced aortic endothelial-dependent dilation in control animals, but not in
the ecig0 and ecig18 mice, indicating that reduced NO has a major influence in the
response we report. Among the many etiologies that can underpin endothelial dysfunction
(e.g., cellular senesce, inflammation, hypertension, obesity, etc.), oxidative stress is a
likely contributor to vaping-induced vascular dysfunction. For example, treating human
vascular endothelial cells with ecig aerosol extract has been found to induce reactive
oxygen species, cause DNA damage, reduce cell viability, and trigger apoptotic
pathways, while anti-oxidant treatment partially rescues the induced cell death (43).
Moreover, chronic ecig use in humans and animals are associated with greater oxidative
stress (44, 45), and as little as 10 puffs of ecig aerosol inhalation can trigger increases in
circulating endothelial progenitor cells (EPC) (46, 47). EPCs are thought to be biologic
marker for vascular function and correlate with cumulative vascular risk (48). These
mechanisms, including the potential for epigenetic, transcriptional, and endoplasmic
reticulum stress have all been implicated in developmental origins of disease (35, 49),
highlighting the potential for vaping to compromise the maternal-fetal dyad circulatory
system (46, 47). In our study, when we sought to evaluate the role of oxidative stress with
tempol (i.e., a SOD mimic that catalyzes the disproportionation of superoxide) or
febuxostat (i.e., an inhibitor of xanthine oxidase, which under hypoxic or inflammatory
conditions produces hydrogen peroxide and superoxide), both restored aortic endothelialdependent dilation suggesting that presence of a pro-oxidative environment. These
findings highlight that oxidative stress is an important and critical factor in the etiology of

56

the vascular dysfunction we see young- and adult-age offspring whose risk stem only
from perinatal ecig exposure due to maternal vaping, but they do not exclude the potential
for other factors to be involved too. For example, in our previous report (24), we have also
seen changes in the number of circulating extracellular vesicles (EVs). EVs are released
from many different cell types and are thought to be an early sign of cellular injury leading
to chronic disease, including endothelial dysfunction. Though we have not yet identified
the source(s) of EVs in our animals, given that aorta responses to SNP and U46619 were
not different that controls (Fig. 4) suggests the smooth muscle function was not impaired,
and might suggest the changes we see may stem from EVs originating by endothelial
cells. Indeed, EVs are implicated in epigenetic alterations following e-cig exposures (19,
20) which could also contribute to the vascular impairments we observe here.

Electronic cigarette aerosol
We know the e-cig cloud is a complex aerosol mixture comprising of particles and
gaseous components (50, 51), and while it is still unclear which subset(s) of potential
toxicants triggered the response(s) that led to the developmental cascade that manifested
the phenotype in our offspring, it is clear from our physical analyses of the ecig cloud (24)
the particles produced are optimal for lung parenchymal distribution that are implicated in
cardiovascular pathogenesis (10). Although we cannot exclude the possibility that the
flavoring (French Vanilla) we used contributed in some way to the phenotype observed,
reports from recent studies suggest similar level of vascular dysfunction performed
without any additives (i.e., only VG and PG)(52, 53). We can exclude nicotine in the
etiology of vascular dysfunction we observed (at least at the concentration we used 18
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mg/ml), since e-cig0 and e-cig18 exhibited similar levels of dysfunction. Thus, we believe
the main contributor to vascular phenotype we observe stems directly from the base
solution. Indeed, there are many known toxicants (e.g. carbonyl compounds, volatile
organic compounds, and metals) that are released when the base component of e-liquid
[i.e. propylene glycol (PG) and vegetable glycerin (VG)] are heated. Many of these
compounds are proven to be developmentally toxic (54-56). For example, cardiotoxic
metals (such as lead, nickel, chromium, and manganese, and sometimes even arsenic)
have been measured in ecig users. At least one study, has confirmed ecigs as a source
of cardiotoxic metals that uniquely damage the vascular system (57). A possible
mechanistic pathway may involve sequestration of intrinsic metals in the body due to
Humic-like substances (HULIS) which has been proven to disrupt iron homeostasis
resulting in adverse cardiovascular, pregnancy, and perinatal outcomes (58). Thermal
degradation of the base solution into carbonyl compounds continues to be an area of
great interest and concern. A recent study has confirmed that inhalation exposure to
formaldehyde alone produces similar impairment to aortic function as with e-cig aerosol
(59), supporting the notion the aerosolization of the base solution may be the primary
source of harm. That is not say that nicotine and/or flavoring may not also have the
potential to cause harm, but rather their effects are likely to be added on top of that
stemming from the base components (VG/PG). The extent to which any or all of these
players impact the gestational and postnatal dynamic is an area requiring further
research.
Most pregnant women who are dual users (i.e., smoke and vape) use their ecigs
daily with a nicotine concentration between 1-6mg (60) and a national sample of pregnant
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women with vaping during late pregnancy, either exclusively or dual-use, shows an
increased risk of small-for-gestational age compared to non-users (adjusted OR 2.4, 95%
CI 1.0-5.7 for sole vapers, and OR 2.3 95% CI 1.3-4.1 for dual-users)(61). The
developmental toxicity of nicotine (22) is well-described, with nicotine exposure leading
to altered size, weight, tracheal development, metabolic changes, and liver dysfunction
(18, 62). Some cardiovascular effects of nicotine can plausibly arise via conversion into
cotinine, a metabolite of nicotine, which has subtle yet enduring developmental
consequences. However, in this study, no significant differences in vascular deficits were
observed in pups born to mothers who were administered e-liquid with nicotine absent or
present, indicating the nicotine is not the principal factor driving vascular dysfunction. We
did observe some subtle changes in body composition (i.e. lean vs fat mass, Table 1) in
ecig compared to air offspring, but we did not see significant differences in birth weight or
body mass (up to 7-months postnatally) as might be expected. While a full explanation
for this is not yet clear, we note that others which have shown reductions in body mass
with e-cig exposure have used much greater exposure to nicotine. For example, Orzabal
et al. (63) showed nicotine-containing ecig aerosol exposed Sprague-Dawley dams
exhibited decreased fetal weight by 47%, but used up to 100mg/mL nicotine in the e-liquid
and a more intense vaping paradigm (1-s puffs every 20 seconds for 3 hours a day). At
present, it is not clear what the nicotine threshold needs to be trigger the changes others
have observed, but based on our data is would seem above the 18 mg/ml of nicotine we
used.
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Strengths and Limitations
This is pre-clinical study involving pregnancy exposure in animals and thus caution
must extended if/when attempting to infer human outcomes. Nevertheless, in terms of
inhalation exposures, it is notable that animal studies have consistently and reliably
provided valuable insights into the mechanisms and pathways involved in programming
peripheral disease risk (64). Thus, based on the rapidly growing body of evidence from
animal studies it is more logical to expect the same risks apply to humans, rather than
assume e-cigs confer minimal risk. An added strength of this study is inclusion of male
and female animals in equal, or near-equal ratios. While the numbers available are not
powered to discern sex differences statistically, they do suggest the vascular outcomes
we assessed for these conditions are not likely to be sex-based. However, an important
caveat and potential limitation in this regard is that estrous status of reproductively mature
females can impact vascular reactivity. Since we did not account for the estrous cycle in
our females we cannot fully exclude the possibility that sex differences might be present.
We narrowed the timing of exposure to during gestation and lactation to
understand the consequences of compromised perinatal environment. Pre-clinical and
clinical studies have shown reduced fecundability/fertility due to nicotine-containing ecig
aerosol (62, 65). Pre-pregnancy toxicant exposure may change morphology of maternal
vasculature, and subsequently placental and uterine vascular structure/function. A study
design in which the female rodents be exposed prior to pregnancy, although potentially
more reflective of human patterns of ecig use, would call into question the effects of
vaping on implantation and fertility. While this question is indeed of great interest, it was
not the focus of this study. In this work we cannot separate whether our effect occurred
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primarily from the gestational or weaning periods in development, but early reports from
ongoing studies with gestational-only exposure (limited to GD2-GD21) suggest that it is
the perinatal exposure that is inducing nearly, if not, all of the effect (52, 53). It should be
noted that reproductive studies are typically based on the number of dams studied, so the
relatively small number dams we studied is a limitation when considering the potential for
biological variability. However, we would point out that the histological and physiological
effects in the offspring were robust and consistent (strong in magnitude and low
variability) across litters of the same maternal exposure, thus it also seems unlikely that
adding more dams would ultimately change the outcomes we see and report.
It is important to recognize that there are considerable number of permutations for
ecig parameters (e.g., wattage, nicotine content, puff topography, etc.) and uncertainty
surrounding the interactions of these properties and their potential individual effects. The
two levels of nicotine exposure (0 and 18 mg/ml) in this study serve as a starting point to
understand the vulnerability of a fetus to maternal vaping. But it important to remember
the contribution of each parameter is a complexity that could also influence the outcome.
For example, keeping the same nicotine concentration and simply increasing the watts
(i.e. the temperature used to create the vape cloud) could easily be expected to produce
a very different toxicity profile. The wattage we used (i.e., 17.5 watts) is well within the
normal operating range many humans would/could use with variable-power tank-style ecig devices (as called “mods”)(66), but is higher compared to most pod-type ecig devices
that operate between 5-10 watts (e.g., JUUL, Puff Bar, etc.). With the many permutations
that can exist with ecigs and/or other rapidly evolving tobacco technologies, it will be
important for future studies to better understand and explore the potential of harm.
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Clinical Relevance
Inhalational pollutants affect pregnancy adversely leading to preterm birth, fetal
growth

restriction,

increased

uterine

vascular

resistance,

impaired

placental

vascularization, and/or increased gestational diabetes (67). While direct ecig exposure is
known to trigger adverse cardiovascular outcomes, this study expands our understanding
to include adverse developmental outcomes in offspring due solely to perinatal ecig
exposure (i.e., indirect exposure from maternal vaping). Importantly these preclinical data
suggest maternal vaping creates a hostile fetal environment that has long-lasting impact
to the vascular health in offspring. Given the growing interest by some health care
providers/agency to promote vaping (vs smoking) during pregnancy, it becomes
increasingly important to assess the vascular health of individuals born with history of
indirect ecig exposure due to maternal vaping. It is notable that the relative magnitude of
vascular changes we observe in this study is comparable to other risk factors (such as
high-fat diet, diabetes, obesity and ageing)(24, 30), there is great concern for the future
morbidity and mortality in progeny already conditioned with vascular risk factor,
particularly when these individuals when faced with cardiovascular (e.g. myocardial
infarct, hypertension, etc) or cerebrovascular (e.g., stroke ) challenge in adolescent or
adult life.

Conclusions
Our study objective was to probe the vascular deficits in offspring that result from
perinatal exposure of maternal electronic cigarette aerosol. Despite the marketing as
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healthier alternatives to cigarette smoking and subsequent widespread public perception
of ecig harmlessness (68, 69), we observed significant long-lasting vascular dysfunction
in offspring with history of perinatal exposure to ecig aerosols (with or without nicotine).
Here, we report (similar to previous evidence in a resistance vessel (24)) that fetal
exposure from maternal vaping during pregnancy triggers subtle, but significant,
disruptions in conduit artery structure and function in offspring that persist into adult life.
A stiffer vessel poses a disease risk factor by itself, and when considering the added
potential of combining added risk factors that can develop during life (e.g. obesity, diet,
sedentary lifestyle, etc.), there is a great concern for vascular health and disease in
offspring experiencing perinatal exposures. These data add to the growing base of
evidence that counters the notion that ecigs are safe, even compared to cigarettes, and
highlight the need for greater awareness that the effects ecigs should be evaluated from
a broader holistic view in health and disease. These data should be used to inform users
and clinicians to track and monitor the vascular health of ecig users; and equally
important, all those born with any history of perinatal exposure.
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Figure Legends

Figure 2-1.
In vivo arterial stiffness data (measured as pulse wave velocity (PWV)) using Doppler
microultrasound of left common carotid artery in (isoflurane) anesthetized offspring at 3and 7-months of age. Offspring only received in-utero exposure from maternal vaping (20
or 60 puffs per hour/day) with (18 mg/ml) or without (0 mg) nicotine (Ecig18 and Ecig0,
respectively). Ecig0 at 20 and 60 puffs (6.8±0.5, 7±0.7) and Ecig18 at 20 and 60 puffs
(6.0±0.5, 7.2±0.6) showed higher PWV compared to controls (3.2±0.2), (effect size
f=2.978, p<0.05 ANOVA main effect). N=10-14/offspring for 3-month; N=3-5/group for 7month. All data shown are mean ± SEM. *p<0.05, ***p<0.001, ****p<0.0001 vs. controls
(Tukey’s post-hoc test where ANOVA is significant). No significant Exposure x Puff
interactions were observed.

Figure 2-2.
Representative photomicrographs (scale bar = 1mm) of abdominal aorta stained with (A)
Verhoeff-Van Gieson for elastin fibers (purple-black) and (B) Masson’s Trichrome for
collagen fibers (blue) showing decreased elastin and increased collagen content in aorta
offspring with history of maternal exposed to e-cigarette containing 18 mg/ml or 0 mg
nicotine (ecig18 and ecig0, respectively) during pregnancy. Controls are offspring with
maternal exposure to ambient air. (C) Density quantification from respective elastin and
collagen images (panel 1) from 3- and 7-month old offspring (expressed relative % to
whole aorta area) and the ratio of elastin/collagen (panel 2). Ecig0 at 20 and 60 puffs
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(0.9±0.1, 0.7±0.1) and Ecig18 at 20 and 60 puffs (0.8.0±0.1, 0.7±0.04) showed higher
PWV compared to controls (1.7±0.2), (effect size f=1.262, p<0.05 ANOVA main effect).
Data are mean ± SEM. N=8 rats per group for 3-month, N=6 rats per group for 7-month
old. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 vs controls (ANOVA, main effect;
Tukey’s post-hoc test where ANOVA is significant). No significant Exposure x Puff
interactions were observed.

Figure 2-3.
Ex-vivo wire myography data showing relaxation responses of preconstricted thoracic
aortic segments to increasing concentrations of methacholine (MCh) in offspring at 3month (A&B) and 7-months (C&D) of age. Maternal exposure occurred with e-cigarettes
with nicotine (Ecig18 = 18 mg/ml) or without nicotine (Ecig0 = 0 mg/ml). Controls are
offspring with maternal exposure to ambient air. Panels B & D show the maximal MCh
dose (i.e., 10-5 M) from 3- and 7-month old offspring (effect size f=9.703, f=9.889),
respectively. All data are mean ± SEM. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 vs
controls (ANOVA, main effect; Tukey’s post-hoc test where ANOVA is significant).

Figure 2-4.
Ex vivo wire myography data showing thoracic aorta maximal responses in 3- (A&C) or
7-month old (B&D) to either sodium nitroprusside (SNP, an endothelium-independent
nitric oxide donor)(A&B) or U46619 (U46, a vasoconstrictor)(C&D). All responses are
shown as a percentage of maximal KCl constriction.
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Figure 2-5.
Data showing effect on the maximal methacholine dose (Mch 10-5 M) responses
(previously shown in Figure 3) when treated with (1) nitric oxide inhibitor (LNAME), (2)
superoxide dismutase mimetic (TEMPOL), and (3) xanthine oxidase (XO)-specific
inhibitor Febuxostat. Thoracic aorta are from 3- and 7-month old offspring who were only
exposed in utero from maternal exposure to e-cigarette aerosol with (18 mg/ml) or without
(0 mg) nicotine (Ecig18 and Ecig0, respectively). Controls are offspring with maternal
exposure to ambient air. All data shown are mean ± SEM. **** p<0.0001
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Table 2-1. Chamber exposure conditions, litter characteristics and anthropometric
measures of offspring
air
20 puffs

ecig0
60 puffs

20 puffs

ecig18
60 puffs

p, ANOVA
Exposure

Puff

Exp x
Puff

Chamber conditions
Total particle count
(#/cm3)

1.4 ± 0.5
x1010

2.5 ± 2.4
x1010

1.5 ± 0.3
x1010

1.8 ± 1.1
x1010

20.2 ± 0.2
44 ± 14

1.4 ± 0.4
x106
22.7 ± 0.7
62 ± 6

1.6 ± 2.0
x106
22.7 ± 1.1
48 ± 16

1.5 ± 0.3
x106
21.2 ± 0.8
57 ± 7

0.99 ± 0.6
x106
22.6 ± 1.4
56 ± 18

Dams
Dam (n)
Dam age (mo) @ birth
Litter size (# pups)
Litter size (range)
Male pups (% of litter)

5
5.8±1.1
14±1
12-16
44

5
5.1±2.1
13±1
10-16
43

3
7.7±0.4
11±1
11-12
42

5
5.4±1.9
12±2
9-16
40

3
7.8±0.3
11±4
5-17
39

Offspring
Body mass @ birth (g)

7.0±0.1

6.4±0.2

6.1±0.2

6.6±0.2

6.4±0.2

40.9±0.7
89.7±0.01
9.8±0.01

39.2±1.1
88.3±0.01*
11.4±0.01*

40.2±0.7
87.5±0.01*#
12.0±0.01*

39.2±1.1
89.2±0.02*^
10.0±0.01^

41.3±0.4
88.8±0.02*^
10.5±0.01*^

3-month old
Total n (# of males)
Age (days)
Body mass (g)

15 (7)
94±1
398±36

14 (7)
96±2
388±38

12 (6)
94±2
425±45

10 (5)
99±3
293±38

12 (6)
94±2
407±36

7-month group
Total n (# of males)
Age (days)
Body mass (g)
Lean Body Massb (%)
Body Fat Massb (%)

10 (5)
228±3
536±45
68.0±0.1
32.0±1.3

8 (3)
226±4
377±50
73.9±0.1*
26.1±1.4*

6 (3)
227±7
508±38
64.3±0.1*#
35.6±1.2*#

8 (3)
226±3
482±29
72.1±0.1*^
27.9±0.9*

6 (3)
227±4
424±36
69.1±0.1
30.9±1.0

102±4
76±4

109±6
83±6

110±4
72±3

103±5
77±4

107±5
78±2

85±4

92±6

85±3

86±5

87±2

342±9

348±13

350±8

306±7

344±8

Average particle count
(#/cm3)
Temperature (C)
Relative humidity (%)

21-23 days old (weaning)
Body mass (g)
Lean Body Massa (%)
Body Fat Massa (%)

Blood Pressure
Systolic BP (mmHg)
Diastolic BP (mmHg)
Mean Arterial Pressure
(mmHg)
Heart Rate (beats/min)

2.8 ± 0.4
x104
1.56 ± 0.2

†

n/a

†
†

†
†

†

†
†

†

†
†

Mean±SEM. TPM, total particulate matter measured gravimetrically; nd, not detected.
ameasured by echoMRI, bmeasured by DEXA. p<0.05 compared to (*) air; (#) 20vs60
puff for same e-cig condition, (^) ecig0 vs ecig18 with same puff number. †p<0.05
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Figure 2-2.
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ABSTRACT
Electronic cigarettes (e-cigs) have been promoted as harm-free or less-risky than
smoking, even for women during pregnancy. These claims are made largely on e-cig
aerosol having fewer number of toxic chemicals compared to cigarette smoke. Given that
even low levels of smoking are found to produce adverse birth outcomes, we sought to
test the hypothesis that vaping during pregnancy (with or without nicotine) would not be
harm-free and would result in vascular dysfunction that would be evident in offspring
during adolescent and/or adult life. Pregnant female Sprague Dawley rats were exposed
to e-cig aerosol (1-hour/day, 5 days/week, starting on gestational day 2 until pups were
weaned) using e-liquid with 0 mg/ml (E-cig0) or 18 mg/ml nicotine (E-cig18) and
compared to ambient air exposed controls. Body mass at birth and at weaning were not
different between groups. Assessment of middle cerebral artery (MCA) reactivity revealed
a 51-56% reduction in endothelial-dependent dilation response to acetylcholine (ACh) for
both E-cig0 and E-cig18 in 1-month, 3-month (adolescent), and 7-month old (adult)
offspring (p<0.05 compared to air, all time points). MCA response to sodium nitroprusside
(SNP) and myogenic tone were not different across groups suggesting that endothelialindependent responses were not altered. The MCA vasoconstrictor response (5hydroxytryptamine, 5-HT) was also not different across treatment and age groups. These
data demonstrate that maternal vaping during pregnancy is not harm-free and confers
significant cerebrovascular health risk/dysfunction to offspring that persists into adult life.

NEW & NOTEWORTHY
These data established that vaping electronic cigarettes during pregnancy, with or
without nicotine, is not safe and confers significant risk potential to the cerebrovascular
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health of offspring in early and adult life. A key finding is that vaping without nicotine does
not protect offspring from cerebrovascular dysfunction and results in the same level of
cerebrovascular dysfunction (compared to maternal vaping with nicotine), indicating that
the physical and/or chemical properties from the base solution (other than nicotine) are
responsible for the cerebrovascular dysfunction that we observed.

INTRODUCTION
Electronic cigarettes (e-cigs) are a new and increasingly popular nicotine delivery
system. Proponents for e-cigs suggest they are a healthier alternative to smoking, and
therefore should be considered a harm reduction tool and an aid to smoking cessation [1,
2], including during pregnancy.[3] However, the limited knowledge stemming from chronic
exposure, particularly in vulnerable populations like youth and during pregnancy, is a
cause for great concern. Moreover, the benefits of vaping for smoking cessation are being
questioned as more robust clinical studies are conducted.[4-6] The case for harm
reduction may also be viewed as somewhat dubious since: 1) the majority of current users
are young (<25 years old) who vape for pleasure rather than smoking cessation [7]; and,
2) the consequence of vaping is increasingly found to affect multiple organ systems.[8]
For example, immune [9] and platelet function [10, 11] are found to be altered, where
vaping can enhance platelet activity resulting in enhanced aggregation and cell-signaling
thus increasing the risk for thrombogenic events (Qasim et al., 2018). There is evidence
of oxidative stress and epigenetic modifications that occur in response to vaping.[12, 13]
Further, in both humans and animals, vaping has been shown to increase blood vessel
stiffness and induce vascular dysfunction [14-18], with some studies showing similar
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damage/dysfunction between tobacco and e-cigs.[16, 17] Impaired vascular function is
notable, as it is widely recognized with advanced aging [19] and is also associated with
neurocognitive decline [19-22], development of cerebral microbleeds [23], lower cerebral
blood flow [24, 25], dysfunction of resistance arteries [19, 26], Alzheimer’s Disease [20,
22, 27], hypertension [28], and greater overall risk for cardiovascular and cerebrovascular
disease.[29, 30]
It is estimated that almost half of all women who smoke prior to becoming pregnant
will continue smoking during and after pregnancy.[31, 32] A growing number of pregnant
women who smoke are being encouraged to switch to use e-cigs [3, 33, 34] based on the
perception that vaping is ‘safer’ than smoking.[1] This is concerning since little is known
about the overall health consequences of long-term e-cig usage, and even less in the
context of pregnancy. Given that smoking [35-37], and even ambient air pollution [38],
are known to trigger adverse birth and adolescent outcomes (e.g. low birth weight,
impaired lung and brain development, impaired adolescent learning/neurocognitive
performance, and vascular dysfunction), it is critical to understand the potential threat of
vaping on vascular development/function during this vulnerable period. Given that vaping
is known to induce vascular dysfunction [14-18], we tested the hypothesis that maternal
vaping during pregnancy, with or without nicotine, would result in impaired
cerebrovascular reactivity in progeny, and that the impairment would be evident during
early adolescent and adult life.

MATERIALS AND METHODS
Study design and exposure system
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All procedures were approved by the West Virginia University Animal Care and
Use Committee. Male (250-275 grams) and Female (200-250 grams) Sprague Dawley
rats were purchased for breeding (Charles River, Wilmington, MA) and housed in
pathogen-free vivarium facility at West Virginia University. They were allowed to acclimate
to the new facility for at least 7 days prior to breeding, provided standard rat chow and
tap water, and kept on 12:12 day:night cycle, throughout the study.

Estrous was

confirmed from vaginal smear, after which male and female rat were housed together (in
the morning) for up to 24 hours. Evidence of pregnancy and determination of gestational
day (GD)-0 was made with observation of sperm and/or vaginal plug on the female. Once
pregnant, rat dams were randomly assigned to receive exposure to each of the following
groups: 1) E-cig aerosol with no nicotine (E-cig0, n=5); 2) E-cig aerosol with 18 mg/ml eliquid nicotine (E-cig18, n=5); or 3) ambient air (control, n=5) (Table 1). Pregnant dams
with the same exposure conditions were housed together, up to 2 per cage, until just
before giving birth (i.e. GD20), at which time dams were individually housed. E-liquid used
in this study was obtained from a local e-cig distributor (i.e. VapeHut), and we used 75/25
VG/PG composition with French Vanilla flavor with and without nicotine (as noted above).
Maternal exposure began on gestational day 2 (GD2) using a whole-body
exposure system (Scireq inExpose, Montreal, QC), and continued (for dams only) until
pups were weaned on postnatal day 21 (PD21). We choose to perform exposure only
during pregnancy and lactation to solely evaluate the influence of vaping whilst pregnant,
and eliminate the potential for any influence that vaping prior to pregnancy might have.
E-cig0 and E-cig18 exposures were performed concurrently using two separate, but
identical E-cig devices and exposure chambers that were independently operated and
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monitored. The rat pups themselves were never placed in the exposure chamber and
were never exposed to e-cig aerosol. Offspring were sacrificed 1-, 3- and 7-months of
age and ex vivo vessel function studied using pressure myography. Selection of offspring
for each time point was made randomly within each litter, with the exception that we
sought (as much as possible based on sex availability) to attain balanced representation
of male and female rats at each time point for each group. One to three pups were used
from each litter at each time point from each group. See Table 2 for sex distribution and
total number of offspring studied in each group.
Maternal exposure consisted of 20 puffs, using one puff every 3 minutes for 60
minutes, from identical third generation, tank-style, e-cig devices purchased online
(Joyetech eGrip OLED). Atomizers were changed once a week. Our e-cig device was
controlled using a custom-made cradle and computer-controlled solenoid (i.e. artificial
hand and thumb) to allow precise and reliable activation of the e-cig device (without
modification to the e-cig device itself). E-cig puff duration was set to 5-sec and with watts
set at 17.5W. An inhalation draw of ~1 LPM was generated by the computer-controlled
exposure system. A continuously bias flow of 5 lpm of air was used throughout the
exposure in the chambers.

Aerosol Analysis
The concentration and size of the aerosol particles were analyzed separately using
condensation particle counters (CPC Model#3775, TSI Inc.) and an electrical low
pressure impactor (ELPI+, Dekati Ltd), respectively. Assessment of the vape cloud
showed

a

complex,

but

similar

distribution

pattern

between

the

respective

90

devices/chambers, resulting in a median particle diameter of 0.395 μm and 0.336 μm for
E-cig0 and E-cig18, respectively (Figure 1). Control conditions showed very wide and
negligible detection of particles in ambient air (Figure 1). Total particulate matter (TPM)
concentrations were determined by conducting gravimetric filter readings from the
exposure chambers during exposures (0.45um pore size 37mm diameter PTFE filters
with 1.5 LPM sample flow).

Collection and Baseline Assessments of Middle Cerebral Arteries
At the appropriate study group age, offspring were deeply anesthetized by
isoflurane and then euthanized by exsanguination using PBS solution to flush the
vascular system of blood via intracardiac (left ventricle) puncture. The brain was removed
from the skull and placed in cold physiological salt solution (PSS; 4ºC). Both middle
cerebral arteries (MCA), which supplies ~50% of the cerebral blood flow [39], were
dissected from their origin at the Circle of Willis and placed into an isolated microvessel
chamber filled with PSS. Each MCA was subsequently doubly cannulated within a
heated chamber (37°C) that allowed the lumen and exterior of the vessel to be perfused
and superfused, respectively, with PSS from separate reservoirs. The PSS was
equilibrated with a 21% O2, 5% CO2, and 74% N2 gas mixture and had the following
composition (mM): 119 NaCl, 4.7 KCl, 1.17 MgSO4, 1.6 CaCl2, 1.18 NaH2PO4, 24
NaHCO3, 0.026 EDTA, and 5.5 glucose. Any arterial branches were ligated using a
single strand teased from 6-0 suture. A video dimension analyzer connected to the
arteriograph system was used to measure wall thickness (WT) and lumen diameter (LD)
at pressures ranging from 5 to 140 mm Hg, in 20-mm Hg increments. The first

91

measurement was taken at 5 mm Hg because negative pressure is generated at 0 mm
Hg, causing the vessel to collapse.

Measurements of Vascular Reactivity in Isolated MCA
Following cannulation, MCAs were extended to their in-situ length and were
equilibrated to ~70 mmHg to approximate in vivo mean arterial perfusion pressure [40].
Following equilibration, the MCA’s dilator reactivity was assessed in response to
increasing concentrations of an endothelial-dependent dilator (acetylcholine, ACh; 10-9M
– 10-4M), endothelial independent dilator (sodium nitroprusside, SNP; 10-9M – 10-4M), and
a potent cerebrovascular constrictor (5-hydroxytryptamine, 5-HT (serotonin); 10-9M – 104M).

MCA responses to ACh were also measured following acute incubation (30 minutes)

with nitro-L-argininemethylester (L-NAME, 10-4M; an inhibitor of NO synthase, Sigma
Aldrich) and TEMPOL (10-4M), to assess the contributions of nitric oxide (•NO) and
oxidative stress, respectively, in modulating MCA reactivity [41].
Following completion of all procedures, the myogenic and passive responses of
the MCA were examined. Vessels were exposed to each pressure point for 5 min before
readings were recorded. Pressure inner and outer diameter curves were obtained first in
the presence of Ca2+ to observe the vessels’ contractile properties and then in Ca2+-free
PSS to evaluate the vessels’ passive properties.
All calculations of passive arteriolar wall mechanics (used as indicators of
structural alterations to the individual microvessel) are based on those used previously
[42], with minor modification. Media wall thickness, lumen and outer diameters (used as
indicators of structural alterations to the individual microvessel) were determined as
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follows: Media thickness (WT, μm) = Outer diameter − lumen diameter (i.e., OD − LD);
media-to-lumen (M:L) ratio = MT/LD; and percentage myogenic tone (percentage tone) 1
- (active OD/passive OD) x 100.

Extracellular Vesicles (EVs)
Blood was obtained by cardiac puncture at sacrifice, immediately spun at 3000
rpm, 4°C, for 10 minutes. After centrifugation, plasma removed in 200 μl aliquots, flash
frozen in liquid N2 and stored at -80°C until processed. To obtain EVs, frozen samples
were thawed on ice and spun at 1500 rpm, 4°C for 10 minutes to separate plasma and
cell debris. The supernatant was removed and placed in a new tube. Plasma EVs were
purified by centrifugation at 16,500 rpm, 4°C for 1hr. EVs pellet was washed with sterile
and filtered 1X PBS and suspended in 200ul 1X PBS with 1 µL taken and diluted in 1 mL
of 1X PBS. The diluted sample was immediately visualized with a Malvern Panalytical
Nanosight NS300 for particle size and quantity. The remaining plasma was spun at max
speed (13K rpm) for 2 hours at 4°C. The supernatant was removed and 500 µL of 1X
PBS was added. The sample was spun for another hour at max speed at 4 °C. These
samples were later used in the Exo-check antibody array (# EXORAY200A-4, Thermo
Fisher Scientific) to confirm the presence of EVs. Markers for exosomes represented in
the kit included CD63, CD81, ALIX, FLOT1, ICAM1, EpCam, ANXA5 and TSG101.
GM130, a cis-Golgi marker, was also present to visualize any cellular contaminations
within the samples.
Zeta Potential (ZP) was used to measure the surface electrostatic potential of EVs
as an indicator of surface charge and colloidal stability influenced by surface chemistry.
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It was conducted by diluting the purified EVs (1:1000 -1:10,000 with pure 1X- PBS ) to
reach a number per frame of 50 to 500, ideal for Nano Tracking Analysis (NTA) and
measured by Zetasizer Nano Z (Zetasizer Nano Z) at WVU core laboratory. Temperature
was set at 25 °C and 5 cycles at high sensitivity settings were performed per
measurement for a total of three to five measurements per sample.

Data and Statistical Analyses
All data are presented as mean±SEM, except when noted. Normality was evaluated
by the Kolmogorov–Smirnov test. Anthropometric assessments were analyzed by
analysis of variance (ANOVA) for exposure condition, as well as by analysis of covariance (ANCOVA) for exposure by sex.

The vascular reactivity in the MCA was

analyzed by repeated-measures two-way analysis of variance (ANOVA), with a Tukey
post-hoc test to determine differences between doses of ACh, 5-HT, or SNP. Differences
in passive and active mechanical characteristics, and descriptive characteristics between
groups were assessed using a multifactorial analysis of variance (ANOVA) with an
interaction term (time-by-group), and a Tukey post-hoc test to determine differences
between groups, as appropriate. In all cases, p<0.05 was taken to reflect statistical
significance.

RESULTS
Maternal Exposures
Table 1 provides comparison dams and exposure conditions. Fecundity was not
altered as litter size was not different between exposed (E-cig0 or E-cig18) and control (Air)
rat dams (Table 1). There were no significant differences in particle counts and aerosol
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concentration between E-cig0 and E-cig18 exposure chambers; and as expected, a minimal
number of particles were detected in ambient air (control) group (Table 1). Average TPM
concentration was calculated at 117±49 mg/m3 (±SD) and 134±51 mg/m3 for E-cig0 and
E-cig18 chambers, respectively (p=0.34). Small differences in ambient and chamber
temperature (±2.6 C) and relative humidity (±14%) were observed between the exposure
groups during the 1-hour exposure time period (Table 1). However, neither the time spent,
nor the magnitude of difference under these conditions would be expected to be
biologically relevant or alter outcomes that we have reported.
Table 2 shows anthropometric and organ assessments for rat pups. There were no
significant differences in anthropometric measures in rat pups between the exposure groups
at birth or at weaning (postnatal day 21, P21)(Table 2). Body and organ (heart, lung, liver)
were not different within any age or by exposure group (Table 2).

MCA Endothelial Function and Myogenic Tone
Endothelial-dependent dilator (EDD) response of the MCA to increasing
concentrations of ACh are shown in Figure 2. At 1-, 3- and 7-months of age, a significant
time-by-group interaction was evident (Figure 2A), whereby the E-cig0 and E-cig18 rat
pups had >50% reduction in maximal MCA EDD compared to control offspring at 1-, 3and 7-months of age (Figure 2B, deficits range from -51% to -56%, p<0.01). In contrast,
endothelial-independent dilation (EID) response of the MCA to increasing concentrations
of SNP did not differ between exposure groups at any age (Figure 3A). Likewise, the
vasoconstrictor response of the MCA to serotonin (5-HT) did not differ between exposure
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groups at any age (Figure 3B), suggesting the impaired ACh dilation response induced
by vaping were not altered by EID modulation.
Acute co-incubation of the MCA with a NO inhibitor (LNAME) revealed that 5680% of the ACh EDD response was accounted for by NO (as seen by a 56%, 75%, and
80% reduction in MCA dilation to ACh in control vessels in 1-, 3- and 7-month old
offspring, respectively, p<0.05) (Figure 4). Given that 20-44% of MCA reactivity was
present with acute LNAME incubation suggests that other non-NO dependent pathways
remain involved. To further explore the role of oxidative stress on MCA dilation, we also
acutely co-incubated the MCA with Tempol (a superoxide dismutase, SOD, mimic)
(Figure 4). Tempol was effective in restoring maximal EDD of the MCA to ACh in both Ecig0 and E-cig18 exposed rats (Figure 4).
The active pressure-diameter at 60 mmHg (Table 3) indicated that at 1 month of
age, the MCAs from E-cig18 group were larger than the Air controlled rat pups. However,
at 3 and 7-months of age, no differences were evident in active pressure-diameter at 60
mmHg between groups. Furthermore, the myogenic tone was similar between groups at
all ages (Table 3). The MCA passive ID, OD, WT and WLR obtained under calcium-free
conditions were similar between groups at all ages (Table 3).

Extracellular Vesicles (EVs)
Plasma from 1-month old offspring show elevated number and diverging EV
population (based on size) in E-cig0 and E-cig18 offspring compared to air controls
(Figure 5). In general, however, E-cig0 maintained consistency in the peak distribution
across the age groups, but had showed fewer number of EVs at 7-month compared the
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younger 1- and 3-month old counterparts (Figure 5). In contrast, the age groups for Ecig18 animals were less consistent, where offspring showed lower number of EVs at 3months, and then greater number of EVs at 7-months (compared to control).

DISCUSSION
To our knowledge, this is the first report to describe the effects of vaping during
pregnancy and lactation on the health and cerebrovascular function in adolescent and
adult offspring. The significance of our findings are that: 1) vaping during pregnancy
confers risk and harm potential to the cerebrovascular health of offspring in adolescent
and adult life stages; and 2) vaping without nicotine does not protect the offspring from
cerebrovascular dysfunction, suggesting that chemicals in the base solution (other than
nicotine) induce cerebrovascular dysfunction.
It is important to emphasize that the offspring in this study were never directly
exposed to e-cig aerosol. They were only indirectly exposed via maternal vaping. Given
that e-cigs have only been widely available since 2007, the long-term consequences of
e-cig usage in humans are still unclear, with some suggesting an overall public health
benefit with vaping compared to smoking.[43, 44] We studied the effects of maternal
vaping with and without nicotine, and while it seems improbable that nicotine-dependent
humans would vape without nicotine, it is interesting to note (in the context of vascular
function) there was no difference in the cerebrovascular dysfunction observed with or
without nicotine (Fig. 2). The importance of this finding is that the components of base
solution (i.e. VG or PG; and not nicotine) likely account for the vascular dysfunction that
we observed.
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It is worth noting that maternal vaping without nicotine would have the benefit of
eliminating any nicotine-induced harm to the developing fetus. For example, evidence
from rats shows that pregnant dams exposed to e-cig aerosol with nicotine (as with
smoking cigarettes) leads to a reduction in body mass and size of offspring, and
decreases in maternal uterine and fetal umbilical blood flow, whereas these outcomes did
not occur in offspring born to dams exposed to nicotine-free e-cig aerosol.[45] Indeed, the
effects of nicotine during pregnancy have been well studied and is known to adversely
affect offspring growth and development.[46] We, however, did not observed any
differences in body mass between our control and e-cigs groups. The most likely
explanation for this discrepancy is the relatively low exposure (only 20 puffs within 1-hour
exposure window each day) and nicotine-level in the e-liquid (18 mg/ml) that we used.
Whereas, Orzabal et al. [45] using a more intense vaping paradigm (1-second puffs every
20-seconds for a 3-hours each day from GD 5-19) and up to 100 mg/ml nicotine have
observed reduced lower birth weights associated with vaping. Additional factors relating
to puff topology and choices of flavors may also have an added influence. To better
understand the etiology of the harm that is developing, and partition effects associated
with

e-liquid

components,

it

will

be

important

for

future

studies

to

have

chemical/compound analysis of the aerosol exposure(s) in order to allow for more direct
comparison (both within a study as well as across studies) to any exposure paradigms.
Despite the relatively low exposure to our dams, we observed significant (>50%)
vaping-induced cerebrovascular impairment that is typically associated with overt
vascular disease.[47-49] Whether vaping has the same effect on human progeny is not
clear yet. It is worth noting that in some acute exposures, only smoking and vaping with
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nicotine showed increased arterial stiffness.[15, 50] Nonetheless, several studies report
that vaping (with or without nicotine) produce similar unfavorable effects on vascular
function as seen with smoking.[15, 16, 50, 51] Collectively, these data suggest that e-cigs
are not likely to be useful approach to reduce the harmful actions of smoking in the context
of cardiovascular and cerebrovascular disease.
From a toxicological point of view, there are two principal sources of potential harm
from e-cigs. These are: 1) toxic chemical or compounds founded in, or produced from,
the vehicle/base solution (such as carbonyls, volatile organic compounds, etc.); and/or 2)
the generation of fine particulate matter (PM) in the respirable range (i.e. 2.5 um or less,
PM2.5). As a nicotine delivery device, e-cigs (including the one we used) produce almost
exclusively particles in the PM2.5 range (Figure 1) that are optimal for parenchymal lung
deposition and subsequent delivery to the vascular system [52, 53]. Our data indicated
that ~10-20% of the particles produced are in the ultrafine range (PM <0.1 μm) (Figure
1). Ultrafine particles (PM0.1) are of particular interest as they can have cardiovascular
effects that are independent of their effects in the lung (see review [54]). While both PM2.5
and PM0.1 are recognized in the etiology of vascular dysfunction [52, 55, 56], the
mechanisms relating to the developmental origins of vascular dysfunction/disease from
maternal exposure are still poorly understood.[54] Moreover, the real effects of PM0.1 are
also not clear as e-cig aerosol will contain mostly droplets of PG and VG, and whose
breakdown products are readily soluble compared to solid particles that have been
studied from other environmental sources.[53, 57]
There is a large body of literature establishing the presence of carcinogenic and
toxic compounds in e-cig aerosol.[58-63] While it is true that the number of toxic
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compounds are fewer in e-cig aerosol than cigarette smoke, it must be emphasized the
dose/concentration (for any given compound) is more relevant to harm potential than
simply the presence of the compound. Although we did not measure the chemical
signatures of our exposure and therefore cannot know which compounds may be
responsible for the vascular dysfunction we observed, numerous studies have shown that
carbonyls compounds are produced in e-cig aerosol.[58, 64-66] Jin et al. [18] have
recently reported that formaldehyde (produce by heating VG or PG) can induced vascular
endothelial cell dysfunction that is independent of nicotine or flavorants. In addition,
chronic e-cig use reported in humans and animals are associated with greater oxidative
stress [67-69] and a change in autonomic balance to greater sympathetic predominance
[67], which is similar to that observed with smoking.[70]. Both oxidative stress and greater
sympathetic activation are associated with increased risk for cardiovascular events.
Indeed, we have previously reported that chronic exposure of mice to either cigarette
smoke or e-cig aerosol increase aortic stiffness and impaired endothelial-dependent
aortic reactivity.[17] While in vitro studies using e-liquid aerosol extracts have produced
varying results, with some suggesting reduced harm in cultured cardiomyocytes [71], but
other studies show high cytotoxicity and oxidative stress to endothelial cells, epithelial cell
and fibroblasts [72-75] and often showing similar responses as smoking. The observation
that ACh stimulation with L-NAME (Figure 4) reduced MCA reactivity in control animals,
but did not alter the impaired E-cig0 and E-cig18 responses, indicates that reduced
bioavailability of NO has a major influence in the response we report. This finding is
consistent with evidence that both smoking [76] and vaping [51] leads to reduce NO
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bioavailability, and likely explains most (but not all) of the cerebrovascular dysfunction
that we see in offspring with maternal e-cig exposure (Figure 4).
We saw no exposure-related differences in cerebrovascular responses to SNP
(Figure 3) demonstrating that the vascular smooth muscle response was not impaired,
and that the MCA is capable of fully dilating if NO is provide via endothelial-independent
sources. However, the fact the ACh with L-NAME did not completely abolish MCA
reactivity indicates that the impairment we observed can only be partly explained by
reduced NO bioavailability (Figure 4). When examining the cerebral vessels response to
ACh in the presence of L-NAME, we only found a difference in E-cig18 compared to air
in the 1-month old group. This could suggest an effect of nicotine that was only present
in early life, as this difference between the E-cig0 and E-cig18 did not persist in the older
(3- and 7-month old) offspring. An opposite effect was seen for Tempol (a stable synthetic
compound that mimics the superoxide dismutase) in 1-month offspring, where E-cig0
response was not fully rescued, as was seen for E-cig18 (Figure 4). The fact that
responses to L-NAME and Tempol were different between E-cig0 and E-cig18 (at the 1month time point) is, perhaps not surprising, and likely suggests that nicotine is acting on
different pathways. These differences, however, did not persist in the older (3- and 7month old) offspring and therefore appear to be lost as the offspring ages. This could
suggest an effect of nicotine on offspring may only be present in early life, as there was
no difference between E-cig0 and E-cig18 in the older (3- and 7-month old) offspring. The
finding that Tempol fully restored the impaired cerebrovascular reactivity in both E-cig0
and E-cig18 in the older offspring suggests the mechanisms underpinning vascular
dysfunction involves (at least in part) oxidative stress.

101

The effect of vaping with nicotine and its potential health consequences is likely to
be more complex than most current studies are designed to reveal. On one hand, based
our MCA data (Figure 2) it may be tempting to conclude that nicotine is not the principal
effector in the context of cerebrovascular dysfunction. This is consistent with a broad
literature base that says nicotine alone (at least via transdermal application) does not
increase the risk of cardiovascular events.[77-80] Evidence from in-vivo animal embryo
models also find minimal effects of nicotine only exposure, but greater incidence and
severity of cardiac defects with exposure to either e-cig aerosol or cigarette smoke
extracts.[81] The same study also reports, in vitro exposure to e-cig and smoking extracts
on human embryonic stem cells (hESCs) lowers expression of contractile and
transcription factors.[81] On the other hand, we found fewer changes in EVs in E-cig0
compared to E-cig18 offspring (Figure 5). The is consistent with recent work in humans
suggesting the vaping with nicotine likely elicits cellular stress responses (and release of
platelet vs endothelial-derived EVs) that is different than vaping without nicotine.[45] EVs
are released from many different cell types (particularly endothelial cells), and are
believed to represent early indicator of cellular changes that lead to chronic disease,
including endothelial dysfunction.[82] Although we have not identified the source(s) of
EVs in our data, platelets-derived EVs have been reported to influence and effect smooth
muscle cells.[83] Thus, it is tempting to speculate, given that MCA responses were not
different when conditioned to SNP (Figure 3), it is most likely that the changes we see in
EVs stem from endothelial cells.
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Relevance to humans and study limitations
It is important to recognize that the comparison of animal and human exposure
studies can be confounded by difference in biology and exposure methodology. While
no animal model perfectly recapitulates the human conditions, there are decades of
research that reliably show that tobacco smoke exposure (and more generally exposure
to airborne PM) in rodents induces similar physiological and pathological outcomes seen
in humans. While our vaping exposure was only during pregnancy and lactation and that
may not be analogous to human behavior (who likely would have been smoking/vaping
before becoming pregnant); we sought to determine whether vaping solely during the
most vulnerable period of growth and development would have adverse effects. Although
not examined in our study, vaping prior to becoming pregnant, and continued vaping
during pregnancy/lactation would reasonably be expected to have the same, or perhaps
worse, outcomes for offspring. The fact that we see such robust adverse cerebrovascular
effects within this narrow fetal exposure window should raise alarm and concern and
serve as harbinger for humans.
An additional concern could arise from the stress that accompanied the daily
intermittent separation that pups experienced when dams were removed for vaping
exposure each day (~1 hour/day, 5 days/week) until weaning. It is well recognized that
maternal separation from neonatal pups each day during the first weeks in life can
influence developmental programming, vascular function, and alter neurobehavioral
outcomes [84-87]. A recent maternal separation (3 h/day from PND 2-14) study, using
wire myography, has also observed that mesenteric artery function was impaired in rat
pups at PND21 compared non-separated controls [88]. However, when mesenteric artery
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reactivity was studied just 2 weeks later (at PND35), or as an adult (5-7 months), the
vessel responses were not different than controls [88]. Collectively these studies clearly
establish that early life (e.g. postnatal) stress events can influence vascular function, thus
we cannot exclude the possibility that maternal separation in our study may not have had
some influence in the MCA responses we report. But, it may also be that (at least) some
of influences on vessel reactivity may be short lived, as was observed for mesenteric
arteries at PND21 but not beyond PND35. If the same is true for other vessels (such as
the MCA), then we might expect minimal, if any, influence of maternal separation on the
1-, 3-, and 7-month-old rats we studied.
In our exposure paradigm we used whole body exposure system that resulted in
the 117-134 mg/m3 over 1-hour period. This may by criticized for not being strictly identical
to the intermittent pattern of human smoking/vaping behavior. However, there are several
issues to note. First, our exposure did produce an intermittent exposure pattern. We used
a 5-second puff duration to generate the e-cig aerosol once every 3 minutes. Given that
the total volume of the exposure chamber is 5.5 L, and that we had bias flow (of 5.0 L/min)
of fresh air continually being drawn into the chamber, the resulting steady state time
constant is ~3.6 (meaning that between each E-cig puff ~95-98% of the chamber volume
was flushed with clean air). The result of this is that our animals received exposure to the
aerosol particles in a pulsatile (or intermittent) fashion, similar to humans, with the
opportunity to inhale numerous clean air breaths between subsequent e-cig puffs.
Second, rodents are obligate nasal breathers, whereas adult humans are not. The
consequence of this is not insignificant. In rodents (and humans, if breathing through their
nose), we expect ~80% of the particles inhaled to be filtered via the nasopharynx and
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upper respiratory airways, with <20% of inhaled particles reaching distal airways.[89-91]
Given that humans smoke/vape via their mouths (bypassing nasopharynx filtering), this
filtering effect on the particles is dramatically less. Humans also take deeper (i.e. larger
tidal volume) breaths when smoking/vaping, which increases the bolus number of
particles for each breath, which all together results in greater percentage of particle
deposition. In essence, if one wants to compare the same aerosol concentration between
rodents and humans, the resulting health outcome/consequence in rodents it likely to
underestimate the effect on humans. That being said, an average mass concentration
with TPM up to 134 mg/m3 is consistent with evidence for a light to moderate smoker.[9294] But it is interesting to note, this mass concentration was achieved with only 20 puffs.
When comparing the number of puffs/day to human use, evidence in the literature [95]
and from e-cig devices that self-report [96] suggest a median of ~100 puffs/day (more
than five times higher than our exposure to rodents) but with a wide preference range
(median absolute deviation = ±72 puffs/day). Given the evidence of vascular dysfunction
we report from only 20 puffs, it seems likely our finding may only be the ‘tip of the iceberg’
and likely underestimates the vascular harm potential to the vast majority of humans who
vape. The clinical significance of this observation is that there may be no safe level of
vape exposure to the user (and potentially even to secondhand exposure), and that even
very low levels of vaping during pregnancy (i.e. 20 puffs/day, or less) will have a significant
negative impact on the vascular health of offspring exposed in utero.
While we purposely sought to include both males and females in this work, we did
not have equal representation of sexes in all groups, and do not have the statistical power
to appropriately conduct a separate analysis based on sex, but we can say that
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qualitatively there is no major differences in responses between male and female
offspring in the controls and E-cig18 groups (showing only 1-2 um difference between
sexes). However, it should be noted, the 1-month-old E-cig0 females did have an average
of 4 μm greater vessel diameter responses than males, hinting that an underlying sex
difference might be present. Thus, we cannot rule out the possibility that sex might not
have an influence.

Conclusions
Our data show that subtle, non-lethal, disruptions in maternal/fetal environment
can have a significant influence on fetal development and far-reaching consequences
later in life, a concept known as ‘Barker Hypothesis’ or Developmental Origins of Health
and Disease [97, 98]). Vaping, with or without nicotine, during pregnancy produces
significant cerebrovascular dysfunction which could (particularly when combined with
other potential risk factors, e.g., inborn/genetic vascular anomalies, obesity, diet,
sedentary lifestyle, etc.) result in greater risk for cerebrovascular events in offspring with
in utero exposure. Our data adds to the growing momentum of evidence that counters the
notion that e-cigs are ‘safe’, or even ‘safer’ than cigarettes. These data highlight the need
for e-cigs, or for any novel tobacco product, to be evaluated with a more holistic view of
health (i.e., beyond just the lungs), and more fully evaluated across multiple
organ/biological

outcomes

before

being

considered

‘harm-reduction’

and/or

recommended by health care systems/providers, particularly during pregnancy.
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Table 3-1. Dams and exposure conditions
Air

E-cig0

E-cig18

ANOVA
P value

E-cig0
vs
E-cig18
P value

Dams (n)

5

5

5

-

-

Dam age @ birth (months)

5.8 ± 1.1

5.1 ± 2.1

5.4 ± 1.9

0.87

0.85

Litter size (# pups)

14 ± 2

12 ± 2

12 ± 4

0.25

0.59

Litter size (range # pups)

12-16

10-16

9-16

-

-

Total particle count
(particles/cm3)

2.8 ± 0.4 x
104

1.4 ±
x1010

<0.001

0.23

1.56 ± 0.2

1.36 ± 0.36
x106

1.47 ± 0.26
x106

<0.001

0.24

TPM (mg/m3)

nd

117 ± 49

134 ± 51

<0.001

0.34

Ambient Temperature (°C)

20.2 ± 0.2

22.8 ± 0.7

21.2 ± 0.8

<0.001

<0.001

Relative Humidity (%)

44 ± 14

62 ± 6

57 ± 7

<0.001

0.12

Ave
particle
(particles/cm3)

concentration

0.5

1.5 ±
x1010

0.3

Mean±SD. TPM, total particulate matter measured gravimetrically; nd, not detected.
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Table 3-1.

Table 3-3. MCA active and passive vessel tone (60 mmHg)
1 month

3 month

7 month

Air

E-cig0

E-cig18

Air

E-cig0

E-cig18

Air

E-cig0

E-cig18

Active OD (µm)

82±4

95±4

109±4*

129±3

132±7

147±7

145±5

157±7

165±8

Myogenic Tone %

48±6

45±4

41±4

34±1

36±5

42±2

32±2

34±3

30±3

Passive ID (µm)

116±13

133±9

133±8

131±3

140±10

140±12

137±5

144±8

149±7

Passive OD (µm)

140±18

166±9

171±10

174±4

184±16

196±13

194±7

207±11

210±9

Passive WT (µm)

12±3

17±2

19±2

22±1

22±3

28±2

28±2

31±2

31±2

WLR

0.19±0.03

0.26±0.03

0.30±0.04

0.33±0.02

0.31±0.03

0.42±0.03

0.42±0.04

0.44±0.03

0.42±0.02

Outer diameter (OD), Inner diameter (ID), Wall thickness (WT), Wall-to-lumen ratio (WLR). *p<0.05 vs. control (Air) within age group.
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Figure Legends

Figure 3-1.
Representative distribution of particle size obtained using a commercially-available tankstyle, Joyetech eGrip OLED E-cig device without nicotine (E-cig0, middle panel) and Ecig with 18 mg/ml of nicotine (E-cig18, bottom panel). Compared to ambient air conditions
(top panel), both E-cig0 and E-cig18 produced >3 orders of magnitude in aerosol
concentration, however, similar droplet size distributions were noted for both of the E-cig
exposure groups (count median diameter E-cig-0 = 0.395 vs. E-cig18 = 0.336 μm) with
devices settings at 5-sec puff duration at 17.5 watts.

Figure 3-2.
(A) Ex vivo pressure myography data examining the endothelial-dependent dilatory
(EDD) response of the middle cerebral artery (MCA) to acetylcholine (ACh). The EDD
response of the MCA was ~50% impaired compared to controls (in offspring at 1-, 3- and
7-months of age) from in utero exposure to E-cig aerosol with nicotine (18 mg/ml, E-cig18)
or without nicotine (0 mg/ml, E-cig0) due to maternal vaping during pregnancy. Controls
(Con) are offspring with maternal exposure to ambient air. Mean ± SD. ANOVA for Age x
Exposure Interaction for maximal ACh response (10-4 M) is p<0.0001. Within each age
group, ANOVA main effect for exposure group x drug [conc] where ++ p<0.05 and ##
p<0.01.
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(B) Age-related summary of offspring’s maximal MCA response (ACh 10-4 dose) shown
as % change relative to baseline tone. Mean ± SD. Fischer’s post-hoc testing for group
differences, *p<0.05.

Figure 3-3.
Ex vivo pressure myography data examining the endothelial-independent dilatory (EID)
response of the middle cerebral artery (MCA) to sodium nitroprusside (SNP, panel A)
and the vasoconstrictor responses to (panel B) serotonin (5-HT). No differences were
noted in EID or the vasoconstrictor of the MCA in offspring at 1-, 3- and 7-months of age
with in utero exposure to E-cig aerosol with (18 mg/ml) or without (0 mg) nicotine (E-cig18
and E-cig0, respectively) due to maternal vaping during pregnancy. Controls are offspring
with maternal exposure to ambient air. All data shown are mean ± SD. ANOVA for Age x
Exposure Interaction for maximal SNP and 5-HT response (10-4 M) are p=0.99 and
p=0.63, respectively.

Figure 3-4.
Data showing maximal acetylcholine dose (ACh 10-4 M) responses using pressure
myography on ex vivo middle cerebral arteries (MCA) treated with nitric oxide inhibitor
(LNAME) and superoxide dismutase mimetic (TEMPOL) in offspring at 1-, 3- and 7months of age with in utero exposure to E-cig aerosol with nicotine (18 mg/ml, E-cig18)
or without nicotine (0 mg/ml, E-cig0) due to maternal vaping during pregnancy. Controls
are offspring with maternal exposure to ambient air. ACh data are same in Figure 2B,
shown here for comparison of individual inhibitor effects. All data shown are mean ± SD.

113

ANOVA for Age x Exposure Interaction for maximal ACh + Lname and ACh + TEMPOL
response (10-4 M) is p<0.0001 and p<0.001, respectively. * p,0.05, ** p<0.01

Figure 3-5.
Data showing extracellular vesicles (EVs) number and size-distribution in plasma
obtained from offspring with in utero exposure (due to maternal vaping) with E-cig aerosol
with nicotine (18 mg/ml, E-cig18) or without nicotine (0 mg/ml, E-cig0). Controls are
offspring with maternal exposure to ambient air.
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Maternal electronic cigarette aerosol exposure during gestation and weaning
alters cognitive functions in early life of offspring
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ABSTRACT
Electronic cigarettes (e-cigs) have been shown to have adverse health effects.
Women of childbearing age, including pregnant women, use e-cigs despite unproven
claims of perinatal safety of these products. The objective of this study was to evaluate
the effect of e-cig exposure during pregnancy on patterns of learning, memory, and
emotional reactivity (i.e., anxiety) in young offspring. We hypothesize that maternal
vaping would produce early cognitive (spatial and aversive learning, short- and long-term
memory) and behavioral alterations in the progeny. Pregnant Sprague-Dawley rats were
whole-body exposed to e-cig aerosol (with 18ml/mg nicotine, ecig18; or without nicotine,
ecig0) using two different dose conditions (20 and 60 puffs/day). The 1-month-old
offspring were assessed for locomotion and anxiety (open field, OF), working memory (Ymaze), aversive learning (step-through passive-avoidance, STPA), and spatial
learning/memory (Morris water maze, MWM). To summarize results, offspring from the
60-puff maternal exposed groups (ecig0 and ecig18) exhibited hyperactivity (increased
locomotion in OF, higher speeds in Y-maze and MWM), increased exploratory behavior
(increased rearing, preference for center zone in OF, latency to enter dark box in STPA),
impaired short-term memory (decreased spontaneous alterations in Y-maze, increased
latency in STPA retention trials), and impaired long-term/reference memory (increased
latencies to find escape platform and poor probe trial performance) compared to controls.
For most assessments, offspring from the 20-puff maternal exposure condition were not
different then controls, with the exception for OF testing - where they exhibited
hyperactivity similar to that found with the 60-puff groups. The results herein provide
evidence of cognitive dysfunction as a result of e-cig exposure in utero and should be
warning that vaping during pregnancy should not be viewed as safe.
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INTRODUCTION
Electronic cigarette (e-cig) use during pregnancy is a growing public health
problem.[1-7] This crisis is heightened by a limited understanding of the toxicological
impact of e-cigs on neurocognitive development, as seen by nearly similar rates of e-cig
use among pregnant and nonpregnant women. [7] While the motivation for women of
child-bearing age to vape includes a perceived “safer” alternative to conventional
cigarette smoking and/or a smoking cessation tool, the CDC maintains that e-cigs are not
approved by the FDA to help adults, including pregnant women, to quit smoking (CDC,
2019).
Environmental insults sustained during gestation can result in altered cognitive
outcomes in offspring, including delayed motor skills, difficulty learning, poor memory,
and poor problem-solving skills. The literature recognizes maternal factors of
hypertensive pregnancy, preeclampsia, antenatal stress, smoking, substance abuse,
obesity, immune activation, among others, as causes of cognitive dysfunction and
behavioral disorders in children. [3, 8-13] A paucity of evidence focuses solely on the
effects of e-cig exposure during pregnancy toward neurobehavioral and cognition-based
outcomes. Where studies exist, maternal exposure to e-cig aerosols in a variety of
paradigms demonstrated significant differences or trends in indices of short-term
memory, anxiety and altered activity. [14-16] However, conclusions across studies have
been inconsistent.
The objective of this study was to evaluate the effect of e-cig exposure during
pregnancy on early cognitive development and behavioral deficits in young offspring and
to evaluate patterns of learning, memory, and emotional reactivity (i.e., anxiety) in novel
environments using multiple and overlapping behavior assessments. Our study design
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also included control tests to verify visual, motivational, and locomotor competence. We
tested the hypothesis that, 1) maternal vaping would produce early cognitive and
behavioral alterations in the progeny, and 2) adverse effects observed would be worse if
maternal exposure was performed at higher dose.

MATERIALS AND METHODS
Animal breeding and exposure
All procedures were approved by the West Virginia University Animal Care and
Use Committee. Male (250-275 grams) and female (200-250 grams) Sprague Dawley
rats (Charles River, Wilmington, MA) were allowed to breed in a pathogen-free vivarium
facility at West Virginia University. Standard rat chow and tap water were provided, and
animals were kept on 12:12 day: night cycle during the study. Upon a successful timed
pregnancy, rat dams were randomly assigned to receive exposure to (1) E-cig vapor with
no nicotine (ecig0, n=5); (2) Ecig vapor with 18 mg/ml e-liquid nicotine (ecig18, n=5); or
(3) ambient air (air, n=5). E-liquid used for each nicotine condition consisted of 75/25
VG/PG composition with French Vanilla flavor that was obtained from a local E-cig
vendor.

Identical tank-style, “mod” E-cig devices purchased online (Joyetech eGrip

OLED) were placed in custom-made cradle with a computer-controlled solenoid (i.e.
artificial hand and thumb) to allow precise and reliable activation of the E-cig device
(without modification to the device itself). E-cig puff duration was set to 5-sec and with
watts set at 17.5W. An inhalational draw of ~1 LPM was generated by the computercontrolled exposure system and a continuous bias flow of 5 lpm of air was flushed in to
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the chambers throughout the exposure, to achieve an intermittent e-cig aerosol exposure
to the animal. Atomizers were changed once a week.
Maternal exposure began on gestational day 2 (GD2) using a whole-body
exposure system (Scireq inExpose, Montreal, QC), and continued (for dams only) until
pups were weaned on postnatal day 21 (PD21). Maternal exposures were either 60 puffs
(number of draws on the activated e-cig device) or 20 puffs.
Ecig0 and ecig18 exposures were performed concurrently using two separate, but
identical e-cig devices and exposure chambers that were independently operated and
monitored. Air dams were handled and transported in similar fashion to exposed dams.
Pups were never directly exposed.

Aerosol Analysis
We have previously reported the concentration and size of the aerosol particles
produced for maternal exposures in this study [24]. In brief, concentration and size of the
aerosol particles were analyzed separately using condensation particle counters (CPC
Model #3775, TSI Inc.) and an electrical low pressure impactor (ELPI+, Dekati Ltd),
respectively. Assessment of the vape cloud showed a complex, but similar distribution
pattern between the respective devices/chambers, resulting in a median particle diameter
of 0.395 μm and 0.336 μm for E-cig0 and E-cig18, respectively. Control conditions
showed very wide and negligible detection of particles in ambient air.
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Behavior Testing
The order of administered behavioral tests was determined by the level of
discomfort it could potentially cause the animal and to eliminate one test’s effect on
subsequent testing. All behavioral assessments were conducted between the hours of
0800 and 1400, to minimize influence of circadian rhythm disruption on rodent
performance.

Open Field Test
Open Field testing was performed on post-natal day (PND) 24. This task evaluates
locomotor activity (fine and ambulatory movement) and anxiety-like behavior of a subject
in a novel environment [17, 18]. The apparatus consisted of a plastic enclosure (40 cm ×
40 cm) surrounding a white open arena. Following a 30-minute acclimation to the testing
room, each subject was placed in the center point of the arena and allowed to freely
explore for 30 minutes. Two 16 x 16 laser beam arrays traverse the arena- one at animal
level, assessing movement in the horizontal axis, while the second array is placed 3.8 cm
above the first and tracks vertical movement, as when the subject stands on its hind legs
(rearing behavior). All locomotor activity was recorded using the Photobeam Activity
System (San Diego Instruments, CA).
Ethological parameters [19] of the test include tendency of the subject to explore
the center zone (approximately 700 cm2) of the arena (exploratory, non-anxious
behavior). Anxiety is determined when an animal favors resignation to the peripheral
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frame of the square enclosure. Number of fecal boli left inside of the end of the 30 minutes
was noted as an additional measure of anxiety status.
Thus, dependent variables were the number of horizontal beam breaks (fine,
ambulatory and total movements), the number of vertical beam breaks (rearing), percent
movement within central versus peripheral zones, and number of fecal boli.

Y-Maze Spontaneous Alternation
Y-maze testing was performed on PND 24. The Y-maze spontaneous alternation
test assesses spatial navigation memory and short-term (working) memory. The
apparatus is a 3-armed enclosure arranged in the shape of a ‘Y’, in which each arm is
available for entry (approximate arm length=38 cm, width=8.25 cm, height=13.25 cm).
After a 30-minute room acclimation period, under indirect dim illumination conditions,
each subject was placed in the maze at the end of one of the arms and allowed to freely
explore for 8 minutes. Spatial cues were available within clear sight of subjects within the
maze to aid in navigation/arm discrimination. Movement, including “freezing” behaviors,
within the apparatus was recorded using the AnyMaze tracking software (Stoelting,
Chicago, IL). The innate tendency of rodents is to generally seek out novelty by
spontaneously alternating between all arms in the apparatus, such that it will enter a less
recently visited arm at most opportunities. Dependent variables for this test include
percent of successful alternations (calculated as (number of correct alternations/(total arm
entries−2)*100), distance (m) traveled within the maze, speed (m/s), and number of fecal
boli.
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Step-Through Passive-Avoidance (STPA)
STPA was performed on PND 25-26. The 2-day STPA test assesses non-spatial
aversive learning and reference memory and was performed as previously described with
few modifications. [20, 21] The STPA apparatus consists of a two-chamber box, one
illuminated and one darkened, which are connected by a guillotine door. Video
surveillance was captured by ANYmaze software. Testing consisted of two phasesacquisition and retention.
Acquisition (learning): This test employs rodents’ innate aversion/fear to brightly lit
environments and tendency to quickly seek refuge in dark compartments whenever
possible. During training, each animal was placed in the illuminated compartment with the
door to the dark chamber open. Once the animal entered the dark compartment with all
four paws, the guillotine door was closed, and the subject received a continuous electric
foot shock (Intensity: 0.3 mA; Frequency: 50 Hz; Duration: 3 s) via electrodes connected
to rungs in a stainless-steel grid in the floor of the dark chamber (T/T Interface Cabinet).
Delivery of adequate shock was verified by ENV420 shock calibration device/software
and noting animal vocalization after shock administration.
Retention: Approximately 10-20 minutes after the initial training, each subject was
again placed in the illuminated compartment and latency (in seconds) to fully enter the
darkened compartment is recorded (immediate retention trial). The trial procedure is
repeated 24 hours post-training to test memory consolidation (24-hr retention trial). Both
retention sessions (immediate and 24-hr) have a maximum cut-off trial time of 300
seconds, and no shocks were administered. Number of fecal boli left after each trial was
noted.
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Dependent variables were latencies(s) to enter dark compartment during each trial.

Hot Plate
Hot plate testing was performed on PND 26. The purpose of this test is two-fold:
(1) it assesses sensitivity of the test subjects to a noxious thermal stimulus thereby
uncovering potential sensoneurological deficits, and (2) it validates other tests in this
study that rely on the experimental animal’s intact tactile sensation (e.g. passiveavoidance and Morris water maze, below). As previously described [22-24], the hot plate
apparatus (Model 39; IITC, CA) was heated to 52.5 degrees Celsius. A test subject was
placed on the hot plate and confined by a tall Plexiglass enclosure. The animal was
videotaped and monitored closely for nociceptive behaviors, which include flicking, licking
of hindlimb or jumping (all four paws lifted from heat surface). The total duration of hot
plate exposure was 30 seconds (well before any tissue damage can occur in SD rats)[25].
The main dependent variable is latency to acute thermal pain (in seconds) which was
determined by the time elapsed after all four paws were placed on the hot plate until first
sign of nociception. Total number of observed nociceptive behaviors and number of each
subtype (flicks, licks or jumps) were also recorded.

Morris Water Maze (MWM)
MWM was performed on PND 27-31. The 5-day MWM evaluates hippocampaldependent spatial navigation memory and reference memory. MWM protocol used for
this study was optimized for age, size and type of rodent. [26]
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Apparatus: A deep circular tub was filled with opaque-black dyed water (to track
white animals within maze) and maintained at a cool 24–26°C (to motivate animal
swimming and pursuit of an escape). The water maze was divided into four quadrants. A
circular platform is positioned 1.5 cm below the water surface. The location of the
submerged platform in the maze remained fixed across all days and trials, except for
during the probe trial (described below).
Acquisition (learning) trials: Experimental animals were placed in water maze (start
locations varying semi-randomly across trials), monitored by an overhead camera and
tracking software. The animals were allowed to swim freely and locate the hidden
platform relative to spatial cues located in the testing room. The trials ends when the
animal finds the platform or the maximum trial duration elapses. If they did not find the
platform in the allotted time, they were gently guided to it. The swim speed and path length
to platform were recorded.
Dependent variables were latency(s) to animal locating the platform (trial duration),
average speed, path length to platform, and path efficiency (determined by software).
4 learning trials per day were performed for 5 days, followed by a final test trial on Day5.
Probe trial (reference memory): The platform is removed. The animal is placed in
a novel start position in the maze and removed after 60s. The object of the probe trial is
to determine whether the animal remembers where the platform was located. Dependent
variables are percent distance in the target quadrant and number of platform zone
crossings.

Data and Statistical Analyses
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All data are presented as mean±SEM. In all cases, p≤0.05 was taken to reflect
statistical significance. One-way ANOVA tests were conducted for endpoint-specific
dependent variables (with or without repeated measures) to address 2-group
comparisons (Ecig0, Ecig18) to air with respect to functional indices. Tukey’s post-hoc
test was applied when there is a main significant effect in ANOVA. Data was checked for
errors and outliers that might affect the analysis.

RESULTS
Open Field: All exposed groups, except ecig18-20puff group, exhibited increased
locomotion in the open field box (ecig0-20puffs 1747±94.7; ecig0-60puffs 1911±117;
ecig18-60puffs 1602±93.9; versus air 1165±93.9, ANOVA p<0.01).
The differences in movement were driven by differences in ambulatory movement
vs fine movement. Both ecig0 and ecig18 groups at 60puffs demonstrated significantly
increased rearing behavior (315±18.6 and 263±23.9, respectively vs air 123±13.9;
ANOVA p<0.01), as well as increased percent movement in the central zone of the
apparatus (ecig0 32±4.6; ecig18 24±3.5 vs air 11±0.9; ANOVA p<0.05). No animals
exhibited deficits in locomotor ability to preclude their inclusion in subsequent testing.

Y-Maze: Figure 2 shows all e-cig exposed groups (except ecig0-20puffs) have
significantly lower spontaneous alternations, expressed as percentage of total
alternations (three consecutive entries, regardless of arm). Successful or spontaneous
alternation is defined when the animal enters a different arm within the Y configuration of
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the maze three consecutive times (e.g., ABC, CAB, BCA, etc), and provides an
assessment of short-term (working) memory. Only the ecig18-20puff group covered a
significantly longer distance within the maze. Both ecig18 groups had a higher speed.

Step-Through Passive Avoidance: Nearly all e-cig exposure conditions
exhibited changes compared to controls indicating altered reference memory and learning
(Fig. 3). In general, these changes appear to be dose dependent, as changes in 60puffs
exposure groups were usually greater than 20puff exposure groups. During the
acquisition or learning phase of the test, ecig0 and ecig18 at 60puffs took a longer time
(compared to control and ecig0 20puffs) to enter the dark box.
Immediately following the learning trial, the 60puff exposed groups did not
demonstrate learning that resignation to the dark box elicits a foot shock (the latencies to
escape the light box was significantly lower than controls). As expected, the latency in
those same groups was again comparatively lower after 24 hrs.

Hot Plate: No significant differences between groups were observed in latencies
to first nociceptive behavior (Fig 4). This further confirms the absence of neurosensory
deficits in the experimental animals that would otherwise confound the data from tests
(specifically STPA) that require intact sensory faculties.

Morris Water Maze: Figure 5A represents performance of the groups in the MWM
across all days of testing. The average path length covered in all trials decreases
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significantly from Day1 to Day5 in air group, as well as ecig0 and ecig18 groups at the
20-puff condition (although these groups are consistently covering more distance every
day). In Fig. 5B, the average path lengths in Trial4 is compared to average Trial1 path
length within each group to assess 24-hr memory consolidation. The significant increase
from T4 to the following T1 in the ecig0 (20- and 60-puffs) and ecig18-60puff groups
reflect an overnight forgetting of escape platform location in these animals compared to
controls.
Shown in Fig. 6A, significant differences were only observed in 60puff exposure
groups (i.e., ecig0 and ecig18), where latency to find the platform, distance traveled (i.e.,
path length), speed, and path efficiency in the test trial (Day5) were greater than controls.
Although 20puffs exposure groups exhibit a similar trend as 60puffs groups, the
differences were not statistically significant.
In the probe trial (Fig. 6B), unsuccessful spatial learning is observed in the 60-puff
e-cig groups, as indicated by a decreased effort looking for the platform in the target
quadrant (lower %distance) as well as a significantly fewer times the animals passed
through the former target location (# crossings in platform zone).
In all analyses, no significant Exposure by Puff interactions were observed.

DISCUSSION
This study evaluated behavior and cognitive function of offspring who experienced
maternal vaping while in utero. The motivation for the study came from a previous
observation of dysfunction in cerebral vasculature of similarly exposed pups [27]. The
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main finding is that we uncover alterations in patterns of learning, memory and anxiety in
the e-cig exposed animals compared to controls, and that many (though not all) exhibit a
dose-dependent effect (i.e., greater changes with 60 puffs than 20 puff exposure).

Learning & Memory
Previous studies implicate prenatal nicotine exposure as the culprit in diminishing
learning efficiency in offspring [12]. Indeed, nicotine alters the reward system acting as
acetylcholine (ACh) agonist on nicotinic cholinergic receptors (nAChRs). In early brain
development, the nicotine may impact the system programming and plasticity in the longterm postnatal life. A key component may be that nicotine derails the acrophase (the best
performance during a 24-h cycle) of learning efficiency [12]. Another explanation may be
that a e-cig exposure prenatally decreases brain glucose utilization, disrupting pathways
of learning and worsening outcomes for offspring with hypoxic-ischemic brain injury [28].
However, our data show in acquisition (learning) phases of two different learning tests
(i.e. STPA and MWM) that maternal vaping during pregnancy, with or without nicotine,
leads to decreased learning efficiency in young adult-age offspring. Though all e-cig
exposed groups showed the same tendency, only the higher level of exposure (i.e. 60puff
conditions) demonstrated a significant difference compared to controls.
The results from Y-maze test, as well as STPA, reveal deficits in short-term working
memory. For the Y-maze, rodents typically prefer and seek novelty, thus remembering a
prior location they entered and exited allows them to alternate from arm to arm within the
maze. Our Y-maze assessment showed e-cig exposed groups had fewer spontaneous
alternations indicating rodents working memory was not same as controls. These findings
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reveal that both spatial (hippocampal-dependent; assessed in Ymaze and MWM) and
nonspatial memory (such as STPA) were affected.
Memory consolidation is another important benchmark for normal cognitive function.
We see impaired memory consolidation in instances where the animals were observed
to learn (more slowly or less efficiently than controls) but not retain the information for
longer periods of time. For example, this is seen the 24-hr trial of STPA (Fig3) and also
in the MWM (Fig5). Another study has also shown that e-cig exposure during
gestation/lactation impaired long-term memory in adult male rat offspring using a radial
arm water maze [29]. Although we only observed short-term memory deficits, collectively
these studies reinforce the notion that maternal e-cig exposure during pregnancy/lactation
has lasting impact and effect in young and adult life-stages of offspring. It is interesting to
note, the long-term memory deficit seen in the radial arm water maze study was
associated with increased activity of superoxide dismutase in the hippocampus, which is
consistent with the SOD pathway involvement that was suggested in our MCA study [27].
An important observation from our work is that the impact vaping during pregnancy
may have on offspring learning and memory may not be exclusively linked to nicotine,
which raises the concerns that even if pregnant women were to choose to vape nicotinefree e-liquid there are still significant health concerns toward offspring development. This
also introduces the possibility that perinatal e-cig exposure may have a more global
impact on the central nervous system than is currently appreciated or described in the
literature.
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Hyperactivity and Anxiety
The Open Field test provides a robust assessment test for locomotor activity (fine
and ambulatory movement) and anxiety-like behavior [17]. Our finding of increased
ambulatory locomotion in e-cig exposed groups is consistent with prior studies in mouse
models that show hyperactivity due to prenatal exposure to e-cigs or smoking [12, 15,
17]. Anxiety behavior is determined by how much time was spent in the central vs
peripheral zones of the open field arena. Our observation was that the higher e-cig
exposed group (i.e. 60puffs) spent significantly more time in the center zone, suggesting
these animals exhibited less anxiety. This finding, combined with increases in rearing
behavior (an index of exploratory and/or risk-seeking tendency), are consistent with other
reports in offspring with perinatal e-cig exposure [16].
Exploratory, or risk-seeking, tendencies in novel environments is abnormal and
potentially dangerous for rodents. Similar behavioral anomalies are seen in offspring of
whose mothers were cigarette-smoking during pregnancy. These behaviors can be
construed as precursors to development of attention-deficit hyperactivity disorder or
impulse control disorders, but it remains unclear if this association exists. Nicotine was
previously thought to be a main contributor to the etiology, but our study shows that
nicotine-free aerosol also elicited these effects. Interestingly, the same cohorts of animals
had a longer latency to go into the dark box in the learning trial of STPA test. Taken
together, these findings suggest a higher tendency for risk-seeking and decreased
anxiety in novel situations. It is tempting to speculate that this could be important because
propensity for substance misuse and abuse in youth begins with a foundation of riskseeking behavior [30-32].
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Strengths and Limitations
A strength of this study comprises a battery of behavior tests to unlock different
aspects of learning and memory and therefore does not rely on any one test to a draw
conclusion. In this respect, we are able to parse out multiple manifestations to uncover
neurocognitive processes from a more comprehensive picture. While our study included
both male and female offspring which does allow some assessment on sex-based
outcomes, given the variability in the data we observed we are not sufficiently powered
to discern sex-based differences. We will note however, there was a trend towards
females performing better than males in many of the tasks. One rationale for this may be
the protective effect of estrogen on progression learning/memory deterioration, since
estradiol serves as a neurotrophomodulatory substance for basal forebrain cholinergic
neurons and thought to be involved in learning and memory [33]. A potential limitation in
this regard is that we did not account for the estrous cycle in our females when behavior
testing was performed.
It should also be noted that statistical evaluation in reproductive studies are
typically based on the number of dams studied, so the relatively small number dams we
studied is a limitation in our study. For behavior studies this is particularly important since
litter effects can drive differences in cognitive performance, thus future work should
include more dams to bring wider range for biological representation.
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CONCLUSIONS
Perinatal e-cig exposure adversely affected learning and memory in young
offspring, while also leading to behavioral alterations of hyperactivity and risk-seeking
behavior. E-cig aerosol exposure that was nicotine-free still impaired cognition across all
tests, which is an indication that pregnant women who wish to cut out the nicotine whilst
vaping have not protected their fetus from potential adverse effects of vaping. Similarly,
lowering the “dose” of e-cig exposure (e..g 20-puffs vs 60-puffs per day) still elicited
changes in outcome, such that cutting back on frequency of vape sessions may not be
enough to eliminate risks to cognitive dysfunction. This is corroborated by vascular data
from the same cohort of animals, showing similar declines in vascular structure and
function when exposed to either 20-puffs or 60-puffs per day [34, 35].
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Figure Legends:

Figure 4-1.
Open Field test performance evaluates locomotion, rearing (exploratory) behavior, and
anxiety. All Ecig groups except Ecig18-20puffs demonstrated significant hyperactivity
(ANOVA p<0.01) compared to controls, driven by differences in ambulatory movement
rather than fine (grooming) movement. Both 60-puff conditions of Ecig groups showed
significantly increased rearing (vertical beam breaks) and increased percent time in the
center zone (ANOVA p<0.01). n=15/group

Figure 4-2.
Y-Maze evaluates working memory. All ecig groups, except for ecig0-20puffs, showed
significantly lower percent of successful spontaneous alternations (ANOVA p<0.05) within
the maze, despite a significantly higher speed shown by the ecig18 groups (ANOVA
p<0.0.01). n=30/group

Figure 4-3.
Step-through passive avoidance task assesses avoidance learning, short-term memory
(immediate retention trial), and memory consolidation (24-hr retention trial). At 60-puffs,
both ecig0 and ecig18 had significantly longer latencies to enter the dark box, suggesting
exploratory tendencies in a novel environment, while also demonstrating significantly
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shorter latencies to enter dark box in immediate and overnight retention trials (ANOVA
p<0.05 and p<0.01, respectively) compared to controls. n=30/group

Figure 4-4.
Hot plate test showed no significant differences between groups. n=30/group

Figure 4-5.
(A) Performance across learning trials by day of Morris Water Maze testing. The average
path length (m) reduces significantly within the air, ecig0-20puffs, and ecig18-20puffs
groups from Day1 to Day5. The ecig0 and ecig18 groups at 60puffs plateau after a
few days without significant change from D1-D5.
(B) Average path length (m) in the last trial (Trial4) of each test day, grouped with
average Trial1 path length of the following Day (i.e., D1T4-D2T1, D2T4-D3T1, …), to
represent overnight memory consolidation of learned platform location. Ecig0 (20and 60-puffs) and ecig18-60puff groups showed significant increase in distance
covered in T1 of the following day (overnight forgetting), compared to air group.
*p<0.05, **p<0.01, ***p<0.001, ANOVA vs controls. n=15/group

Figure 4-6.
(A) In the Morris Water Maze test trial, ecig0 and ecig18 groups at 60-puffs exhibited
significant differences in path length (A1) and higher average swimming speed (A2). A3:
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Ecig0 60-puff group demonstrated a significant latency to locate the escape platform
(ANOVA p<0.05), with a similar trend in ecig18 60-puff group (p=0.068). A4: Path
efficiency in the test trial was significantly lower in both 60-puff ecig groups. (B) In the
probe trial, 60-puff ecig0 and ecig18 groups revealed (1) lower percent distance covered
in the target quadrant (where the platform was previously located), as well as (2)
significantly fewer entries into the platform zone (ANOVA p<0.05), indicating ineffective
search strategy and deficits in spatial learning and memory. n=15/group
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Chapter 5
Discussion and Future Directions

Pregnancy and early life are critical sensitive windows of susceptibility.
Periconceptional, perinatal and postnatal environments can have significant influence on
offspring’s risk for chronic disease development and progression, even in later life. The
purpose of this dissertation was to ascertain consequences of maternal electronic
cigarette (e-cig) aerosol exposure during gestation and weaning on vascular and
behavioral outcomes in the F1 generation. We accept the central hypothesis that maternal
e-cig exposure during pregnancy on vascular and behavioral outcomes in offspring.
The presented series of experiments evaluates arterial structural and function and
concomitant central and peripheral vascular dysfunction as well as characterizing
cognitive function in the offspring. This is the first study to date that (1) investigates two
levels of the systemic circulation-namely, central conducting vessels (aorta and carotid
arteries) and resistance vessels (middle cerebral artery) in the F1 generation at different
time points of life (early, adolescent, adult) following perinatal e-cig exposure (Chapters
2 and 3), (2) suggests potential mechanisms for the developmental origins of these
vascular phenotypes, and (3) associates these outcomes to functional behavioral
impairment (Chapter 4). Further, the study design allows for comparisons between two
levels of exposure, establishing a potential threshold for conferral of e-cig-associated
harm to the vascular system. Finally, the influence of nicotine on the targeted outcomes
is addressed.
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Chapter 2 describe effects of maternal e-cig exposure on central arterial stiffness
and aortic reactivity in the F1 adolescent- and adult-age progeny (at 3-months and 7months of age, respectively). In offspring that have only received perinatal exposure to ecig aerosol, we report a 2-3-fold increase in carotid artery stiffness and ~20-30% deficit
in aortic reactivity compared to controls. Increasing maternal whole-body exposure threefold (from 20- to 60-puffs/hour) did not produce a dose-dependent effect on the targeted
vascular outcomes.
Interestingly, the presence or absence of nicotine in the e-liquid did not significantly
change the deficits observed within any of the e-cig exposed offspring, indicating that the
constituents of the base solution, and not nicotine, is likely the culprit triggering these
adverse effects. Increased arterial stiffness and vascular dysfunction (e.g. flow-mediated
dilation) was previously known and observed in human and animal studies following a
direct e-cig exposure. Thus, another important finding in this study is that similar changes
in central arterial stiffness and endothelial dysfunction was elicited indirectly via maternal
exposure, and the changes observed in adolescent (3-month old) offspring persisted into
adult life (7-months of age) suggesting the vaping during pregnancy likely contributes to
developmental origin of vascular dysfunction.
Chapter 3 extends the findings of Chapter 2 insofar it demonstrates that (1)
resistance vessels, like conduit vessels, are susceptible to gestational e-cig exposure at
the lower e-cig exposure level (i.e 20-puffs/day), (2) oxidative stress pathways are
implicated in vascular dysfunction, (3) vaping without nicotine does not protect the
offspring from cerebrovascular dysfunction, further suggesting that either particles or
chemicals in the aerosol from heating the base solution (e.g., VG, PG, flavoring agents)
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are likely involved in the etiology of cerebrovascular dysfunction, and (4) vascular
changes are seen as early as 1-month-old of age.
Chapter 4 is an extension of Chapter 3 findings in the brain and further exploration
of the functional consequences of cerebrovascular dysfunction. As changes in the brain
vascular function generally carries little meaning without consequent changes in behavior
and cognition, detection and characterization of behavioral impairment following
gestational e-cig exposure is a crucial step in establishing e-cig as a developmental
neurotoxicant.
To underscore the risks of maternal vaping, we used levels of intermittent maternal
e-cig aerosol exposure that represent relatively low exposures when extrapolated to the
equivalent of human real-world use. Our paradigm of maternal e-cig aerosol exposure
(specifically in Chapters 2 and 4) includes two conditions of 20- vs 60-puffs per day to
determine the existence of a dose effect in the targeted vascular and behavioral
outcomes. However, in many cases, no dose effect was observed in the vascular
outcomes, although differences were seen in some (but not all) behavioral endpoints.
This may be because a 3-fold greater number of puffs (with all other power and device
settings remaining unchanged) did not significantly change the average aerosol density
per puff in the exposure chamber. So, although the 60-puff scheme was 3 times longer,
the concentration of aerosol was not different. The extent that particles versus chemical
produced trigger damage in neurodevelopment remains unknown, but becomes an
important question given our findings. In toxicological sciences, most xenobiotic
exposures typically have threshold where there is no-observed-adverse-effect-level
(NOAEL). In the current context, that we observe similar vascular impairment with both
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20- and 60-puff exposures indicates that whatever threshold exists for vaping, it appears
to be very low, or much lower than expected. This is clinically relevant when accounting
for pregnant women who may decide to reduce their e-cig usage in an attempt (albeit
misguided) to reduce harm to their growing fetus, but for all practical purposes such a
low-level of vape exposure in the real-work probably does not exist as most people vaping
(pregnant or not) are unlikely to only vape at 20-puffs/day.
The e-cig cloud is a complex aerosol mixture comprising of particles and gaseous
components containing chemicals. Comprehensive toxicological profiles of individual
components and the way they interact with each other remains elusive. For example,
cardiotoxic metals (such as lead, nickel, and chromium) are damaging to the vascular
system and are proven to be developmentally toxic. As described in Chapter 2, our
physical analyses of the e-cig cloud, cardiotoxic particles are generated in abundance.
Evidence from a number of studies suggest that the flavoring agent used here (i.e.,
French Vanilla) is complicit in the developmental toxicity, as are VG and PG. The
contribution of nicotine notwithstanding, this research supports the notion that the main
contributor to vascular and behavioral phenotypes stems directly from the base solution,
and not nicotine per se.

Vascular outcomes
Increased arterial stiffness (herein characterized by increased pulse wave velocity,
PWV) is meaningful as a predictor of cardiovascular disease development and
progression. Aortic PWV in early infancy is an established index for long-standing chronic
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cardiovascular dysfunction, and subsequently a risk factor for acute coronary events later
in life. This is corroborated by our data, which sees increased PWV in vivo, as well as
associated histological findings of decreased elastin:collagen density ratio, persist in
offspring up to 7 months of age (mid-adult life). Hemodynamic changes, such as elevated
blood pressure (BP), that is independent of structural changes may account for a high
central PWV, thus it was important to address essential hypertension as a confounder in
interpreting results. We observed no significant differences in BP between e-cig-exposed
offspring and controls, emphasizing the contribution of intrinsic mechanisms of structural
alterations and endothelial dysfunction to functional outcome of vessel stiffness.
Endothelial dysfunction is also an important pre-clinical risk factor for
cardiovascular and cerebrovascular disease. We have previously reported that chronic
direct exposure of rodents for 8-months to e-cig aerosol (or traditional cigarettes)
increases aortic stiffness and impaired endothelial-dependent aortic reactivity. In
Chapters 2 and 3, we evaluate the same effect on endothelial-driven vascular reactivity
in aorta and middle cerebral arteries, respectively. Approximately 20-30% deficit was
observed in aortic reactivity and >50% deficit in MCA reactivity in offspring exposed
perinatally to e-cig with and without nicotine. These changes are considerable in their
propensity to cause overt systemic cardiovascular disease and establish a risk offspring
for worsened outcomes when challenged with a comorbidity in later life.

Behavioral outcomes
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It can be assumed that the MCA dysfunction described previously would not be
limited to just the one cerebral artery, but rather affects the cerebrovasculature as a whole
affecting several functional regions of the brain. Thus, it can be expected that more than
one central neural system is affected, including cerebrocortical, hippocampal and
amygdala-related processes, leading to alterations in patterns of learning, memory and
anxiety in the e-cig exposed animals (Chapter 4).
Offspring exposed in utero to e-cig aerosols showed deficits in acquisition phases
of behavioral tests such as STPA and MWM. The deficits we observe in learning efficiency
could be explained by the manipulation of nicotinic cholinergic receptors or decreased
brain glucose utilization, both which create long-lasting effects on the plasticity of the
neural networks. We also observed poorer performance in short-term memory tasks
within the exposed groups compared to controls, as seen in the Y-maze and STPA.
Furthermore, spatial (Y-maze, MWM), non-spatial/aversive memory (STPA), and memory
consolidation were significantly altered, mainly in the 60-puff e-cig exposed groups.
Taken together, these data point to the perinatal susceptibility of cortical and hippocampal
regions of the brain to e-cig toxicants.
The Open Field and Y-maze tests corroborate findings from other studies that
prenatal e-cig exposure results in locomotor changes. In the e-cig exposed groups, we
observed hyperactivity in terms of increased ambulatory movement in the Open Field test
and increased speed of the animals in the Y-maze and MWM. This hyperactivity was
coupled with risk-seeking tendencies and a demonstration of lesser anxiety in novel
environments, a pattern of behavior that can be construed as potentially dangerous for
rodents. These findings raise questions whether an association could exist between
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perinatal e-cig exposure and similar problematic risk-seeking behavior in humans.
Indeed, other studies have described similar phenotypes as foundations for substance
abuse and impulse control disorders in adolescent and later life.

Mechanisms
Toxicological impact of e-cigs arises from chemical compounds founded in, or
produced from, the vehicle/base solution (such as carbonyls, volatile organic compounds,
etc.) and/or the generation of respirable fine particulate matter (PM) that deposit in the
lung parenchyma. The toxicology of these compounds is directly proportional to
dose/concentration, which is more relevant to harm potential than simply the presence of
the compound.
Chapter 3 shows that our devices produced ultrafine particles that can elicit
cardiovascular effects directly and not solely due to lung inflammatory processes.
Humectants in e-cigs, such as PG and VG, could contribute to the toxicant lung burden.[15] Although these are generally considered as safe as food additives, they are readily
soluble compounds and their byproducts have the potential to enter the bloodstream,
disrupting the maternal-fetal circulatory system and causing deleterious effects on fetal
health.[2, 5] Formaldehyde (produced by heating VG or PG) can induce vascular
endothelial cell dysfunction that is independent of nicotine or flavorants.[5] Studies further
show that toxicants in e-cig aerosol induce a pathological sympathetic activation, which
is a known risk for cardiovascular events.[6]
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Oxidative stress is associated with pathological processes seen in aging,
inflammation, hypertension, and metabolic syndromes. This is likewise a potential
etiology for vaping-induced endothelial dysfunction. Indeed, reactive oxygen species
(ROS) generation was previously linked to reduced cell viability and apoptosis following
direct e-cig exposure, as well as DNA damage and increased systemic endothelial
progenitor cells associated with both acute and chronic exposures.[7-10]
The maternal-fetal circulatory system is susceptible to oxidative stress, which
could lead to adverse effects on fetal health outcomes. Oxidative stress is implicated in
cases of incorrect implantation of embryos, miscarriages, premature births, low birth
weight, and malformations.[7, 11, 12] It also weakens pregnant immunity and respiratory
adaptation of newborns immediately after birth. The main reason for these disorders is
the insufficient supply of nutrients and

xygenn to the fetus resulting mainly from

hypoplasia and abnormal placental function.[12]
We investigated the role of oxidative stress by treating aortic rings and MCA with
TEMPOL, a superoxide dismutase (SOD) mimic which reduces the burden of superoxide
free radicals. This rescued the endothelial-dependent dysfunction in aorta of ecig0 and
ecig18 groups in aorta, and in MCA of the ecig18 group. The fact that aortic and MCA
changes were seen in both ecig0 and ecig18 groups at 3- and 7-months, while changes
in MCA were also seen in at 1-month, suggests that resistance vessels may be more
susceptible at early ages, but the deficits remain throughout life. Similarly, the addition of
febuxostat, which inhibits xanthine oxidase and thereby reduces hydrogen peroxide and
superoxide, restored aortic and MCA reactivity to that of controls. These findings highlight
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that oxidative stress pathways are critical in the etiology of the vascular dysfunction from
vaping.
Notably vaping has been shown to reduce nitric oxide (NO) bioavailability, causing
an imbalance between endothelium-derived relaxing and/or contracting factors. Chapter
2 describes a reduction in aortic endothelial-dependent relaxation after methacholine
(MCh) stimulation is treated with L-NAME in controls, but the impairment in e-cig exposed
offspring is not further reduced with L-NAME. Chapter 3 shows that Ach stimulation with
L-NAME reduced MCA reactivity in control animals but did not alter the impaired ecig0
and ecig18 responses. This suggests that reduced NO has an integral role in the vascular
dysfunction observed. Smooth muscle function was not impaired in either aorta or MCA.
Sodium nitroprusside (SNP) offers exogenous NO to the vessel and relies on smooth
muscles uptake to induce vasodilation. This indicates the vascular dysfunction is
attributable to endothelial-driven processes, and not a defect in smooth muscle function
in the vessel wall.
Epigenetic and transcriptional mechanisms may also be responsible for the
vascular dysfunction described here. Extracellular vesicles (Evs) originated from myriad
cells are implicated in epigenetic alterations that contribute to development origins of
disease.[13] Chapter 3 shows a change in the number of circulating extracellular vesicles
(Evs), which could indicate a mechanism of cellular injury associated with endothelial
dysfunction. Further work is needed to identify the source and payload carried by the Evs
to better understood their origin and role in the vascular impairments we observe.
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Nicotine
While the developmental toxicity of nicotine (and its metabolite cotinine) is welldescribed, our studies reinforce that nicotine alone does not increase the risk of adverse
events, especially cardiovascular events. The extent to which nicotine causes
cardiovascular harm seems most likely contingent on the vehicle, as both e-cig aerosol
and cigarette smoke extracts have been shown to compound the risks nicotine confers.
In Chapter 3, we found fewer changes in Evs in ecig0 compared to ecig18 offspring,
which is consistent with human subject studies that suggest the vaping with nicotine
results in the release of endothelial-derived Evs that lead to cellular inflammatory
responses different to vaping without nicotine.
One explanation for the nicotine effect (or lack thereof) seen in our studies could
be that the threshold of nicotine content in e-cigs must be higher to trigger a more robust
independent effect. Another interpretation is that both nicotine and one (or more) of the
other toxicants in the base solution engage similar mechanistic pathways to alter the
outcomes we targeted, possibly creating a synergistic effect that was still overshadowed,
or saturated, by the overall e-cig aerosol effect. Also important to note is that wattage,
puff topography, and other factors relating to the operation of an e-cig device could greatly
influence the toxicology of nicotine, and other constituents of the e-cig cloud. These
considerations are vital to our understanding of how e-cigs confer harm, and will require
further study before a complete understanding can be had.

Limitations
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We used whole-body exposure paradigm (rather than nose-only exposure that
requires body restraint) to limit physical stress to dams during pregnancy. After birth,
dams were also required to be away from their pups for the daily 1-hour exposure.
Maternal separation from neonatal pups can create postnatal stress in the pups during
the first weeks in life, which in turn might also have some influence on developmental
programming, vascular function, and alter neurobehavioral outcomes. But we also note
that control (i.e. air exposed) dams were also separated from their litters in a similar
manner, so any effect here should be accountant when comparing against our controls.
We cannot exclude that prenatal stress sustained by the dams during the exposure
protocol may influence their maternal capabilities and lactation, further causing harm to
the pups and could affect fetal and early life development. While our study design does
not include the duration of separation that has been shown to have significant stress
effects described in other perinatal studies, it is still an important factor to consider.
The whole-body exposure design we used is robust in terms of providing an
intermittent e-cig exposure; after each puff the chamber is flushed out with a clean air to
try and mimic human usage with clean air breaths between exposures. However, residual
components of the cloud may linger on the body of the rats, leading to questions about
third hand exposure. Third hand exposure in this case refers to exposure to components
of the e-cig aerosol once it has physically settled in the surrounding environment.
Grooming, maternal dermal exposure and, in the lactation phase, the possibility of the
newborn pups coming in contact with and/or ingesting e-cig product that lingers on the
mother are possible scenarios that could confound the results reported here.
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Pilot studies for this work, not reported here, suggest the gestational only exposure
have the same outcome and gestational + lactation, suggesting the toxin transfer from
milk or skin are not likely involved in the etiology of vascular dysfunction we report here,
but further studies with the appropriate controls conditions are needed before this
determination can be made. One possible study design to get around dermal and/or
lactational exposure of pups is a cross-foster design, in which a number of pups be
breastfed by the exposed dam while other pups from the same litter breastfed by a control
dam, and comparisons made between the two groups of pups.
Both males and females are included in all studies, and to a large extent equally
represented within all groups. Sex differences have been widely described in perinatal
toxicology, with hormonal effects driving major differences in the extent to which progeny
are affected. While qualitatively and quantitatively there were no observed sex differences
in vascular dysfunction and performance in the behavior tests; our sample size was not
adequate enough to support this observation statistically in all of outcome variables.

Clinical relevance
Pre-clinical studies that employ rat models to evaluate inhalational exposures are
generally accepted as predictors for similar consequences in humans, including studies
wherein the maternal-fetal dyad is concerned. Biological differences between rats and
humans may cast ambiguity on the translational aspects of this research; however, the
data we report herein are substantial alterations to offspring vascular and cognitive health
and therefore a cause for considerable concern for implications on human health. This is
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especially relevant when considering that rats inhale relatively lesser concentrations of
the aerosol, and that systemic effects were still elicited in these animals.
The effects we observed were a result of gestational and lactational exposure and
did not include a pre-conceptional window of harm. This highlights the clinical relevance
and potency of e-cigs as perinatal toxicants since real-world usage would likely include
past history of vaping, or at least conventional cigarette smoking, prior to prenatal use.
These preclinical data suggest inhalational toxicants from maternal vaping creates
a hostile gestational environment, contributing to the concept of Developmental Origins
of Health and Disease (DOHaD).[13] This means that early gestational environmental
insults affects fetal health which manifests as early as infancy and lasts throughout
adolescence and adulthood. Future risks of morbidity and mortality in offspring are
amplified by neurocognitive, motor, and vascular deficits sustained during gestation and
lactation as a result of maternal e-cig use.

Conclusions
This dissertation reports that maternal vaping, with or without nicotine, during
pregnancy triggers disruptions in conduit and resistance vessel structure and function in
offspring that persist into adult life. Offspring born to mothers who are exposed to e-cig
aerosol have stiffer vessels and altered vascular reactivity. This long-lasting vascular
dysfunction is associated with cognitive and behavioral impairment. Perinatal e-cig
exposure adversely affected learning and memory in young offspring, while also leading
to behavioral alterations of hyperactivity and risk-seeking behavior. A key feature of these
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studies is the demonstration that perinatal e-cig aerosol exposure at even low levels and
in the absence of nicotine, still elicited long-lasting adverse health outcomes in the
offspring.
Overall, the dissertation adds to our understanding of the toxicological impact of
novel tobacco products. The research herein contradicts widespread public perception of
e-cig harmlessness and marketing of e-cigs as “safer” alternatives to cigarette smoking
during pregnancy. The results from these studies should raise alarm to clinicians,
policymakers and the public alike, and highlight the need for more research and
awareness to curtail the vaping epidemic especially in vulnerable populations.

Future Directions
As mentioned, there is extensive variability in e-cig design and operation, leading
to the complexity surrounding their toxicology. A challenge that pervades e-cig research
is lack of standardization in methodology and exposure paradigms. While the creation of
a standard cigarette was reasonable and useful for traditional cigarettes, such an
approach does not appear to practical with e-cig given the wide range technology and
different “generation” of e-cig devices and potential options by which the user can alter
the performance of an e-cig device. Thus, it is important for future studies to exercise
more diligence in the analysis of chemicals and compounds of e-cig aerosol exposure in
order to allow for more direct comparisons both within studies as well as across studies.
This could be achieved by isolation of each constituent to evaluate individual toxicological
impact, and further demonstrating which developmental processes are most susceptible
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to each constituent. The extent to which any or all of these players impact the gestational
and postnatal dynamic is an area requiring dedicated research.
Moreover, a vital part of perinatal research is determination of the specific
gestational window that is susceptible to inhalational toxicants. Here, not only is trimester
(or early, mid, and late gestation) important, but also pre-pregnancy use, and how the
maternal circulation might be primed for the risks of perinatal e-cig use. Pre-conception
toxicant exposure may alter morphology of maternal vasculature, leading to placental and
uterine vascular dysfunction. This information would be helpful in providing adequate
healthcare in antenatal clinics and in preventative medicine.
Future studies should further investigate pathways and mechanisms that are
involved in the processes that lead to vascular and behavioral alterations observed here.
There remains a gap in our knowledge of the contribution of lung processes, alterations
in vasculature, placental pathology, or a combination of these and/or other pathogeneses
in the development of offspring dysfunction due to maternal e-cig exposure.
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